* Had signed an agreement with AstraZeneca whereby AGI will
acquire exclusive rights to commercialise astrazeneca's global
(excluding USA) anaesthetics portfolio
Read more
Wednesday, August 31, 2016
Nestle to buy medical device company Phagenesis in stages
ZURICH, Sept 1 (Reuters) - Nestle on Thursday
announced a deal to buy Phagenesis, a British medical device
company working on a new treatment for dysphagia, a condition
where patients are unable to swallow safely.
Read more
announced a deal to buy Phagenesis, a British medical device
company working on a new treatment for dysphagia, a condition
where patients are unable to swallow safely.
Read more
BRIEF-Cerenis Therapeutics Holding presents positive tolerability and safety findings of CER-001
* Announces presentation of a poster on positive
tolerability and safety findings of its drug candidate CER-001,
at occasion of European Society of Cardiology congress
Read more
tolerability and safety findings of its drug candidate CER-001,
at occasion of European Society of Cardiology congress
Read more
BRIEF-Molecular Partners posts H1 net loss of 9.7 mln Swiss francs
* In first half of 2016, Molecular Partners recognized 21
pct higher total revenues of 13.5 million Swiss francs ($13.73
million)(H1 2015: 11.2 million Swiss francs)
Read more
pct higher total revenues of 13.5 million Swiss francs ($13.73
million)(H1 2015: 11.2 million Swiss francs)
Read more
Six Bangladeshi nationals in Singapore infected with Zika
SINGAPORE, Sept 1 (Reuters) - Six Bangladeshi nationals have
been tested positive with the mosquito-borne Zika virus in
Singapore, the High Commission of Bangladesh said on Thursday.
Read more
been tested positive with the mosquito-borne Zika virus in
Singapore, the High Commission of Bangladesh said on Thursday.
Read more
BRIEF-Five Malaysians among those with Zika infections in Singapore - Malaysian health minister
* Five Malaysians among those who tested positive for Zika
in Singapore
(Reporting by Kuala Lumpur newsroom)
Read more
in Singapore
(Reporting by Kuala Lumpur newsroom)
Read more
UPDATE 1-China factory activity unexpectedly expands in August-official PMI
BEIJING, Sept 1 (Reuters) - Activity in China's
manufacturing sector picked up unexpectedly in August but gains
were modest, an official survey showed on Thursday, suggesting
the world's second-largest economy is steadying but still
sluggish.
Read more
manufacturing sector picked up unexpectedly in August but gains
were modest, an official survey showed on Thursday, suggesting
the world's second-largest economy is steadying but still
sluggish.
Read more
China official services PMI expands at slightly slower pace in August
BEIJING, Sept 1 (Reuters) - Activity in China's services
industry expanded again in August, but at a slightly slower pace
than in the previous month, an official survey showed on
Thursday.
Read more
industry expanded again in August, but at a slightly slower pace
than in the previous month, an official survey showed on
Thursday.
Read more
U.S. appeals court rules medical pot cardholders can be denied guns
Aug 31 (Reuters) - A federal appeals court on Wednesday
upheld federal regulations that prevented a woman with a medical
marijuana card from buying a firearm in Nevada, in a ruling that
cited the government's interest in preventing gun violence.
Read more
upheld federal regulations that prevented a woman with a medical
marijuana card from buying a firearm in Nevada, in a ruling that
cited the government's interest in preventing gun violence.
Read more
UPDATE 1-Sunovion Pharma to buy Canada's Cynapsus for $624 mln
Aug 31 (Reuters) - Sunovion Pharmaceuticals Inc, a unit of
Japan's Dainippon Sumitomo Pharma Co Ltd, said it would
buy Canada's Cynapsus Therapeutics Inc for
about $624 million.
Read more
Japan's Dainippon Sumitomo Pharma Co Ltd, said it would
buy Canada's Cynapsus Therapeutics Inc for
about $624 million.
Read more
Sunovion Pharma to buy Canada's Cynapsus for $624 mln
Aug 31 (Reuters) - Sunovion Pharmaceuticals Inc, a unit of
Japan's Dainippon Sumitomo Pharma Co Ltd, said it would
buy Canada's Cynapsus Therapeutics Inc for about $624
million.
Read more
Japan's Dainippon Sumitomo Pharma Co Ltd, said it would
buy Canada's Cynapsus Therapeutics Inc for about $624
million.
Read more
BRIEF-GSK Consumer Healthcare announces Flonase allergy relief for OTC use in Canada
* GSK Consumer Healthcare - Approval of flonase allergy
relief for over the counter use in Canada
Read more
relief for over the counter use in Canada
Read more
BRIEF-AstraZeneca announces results from SYMBICORT study
* SYMBICORT demonstrated comparable risk of serious
asthma-related events and lower risk of asthma exacerbations
compared to Budesonide alone
Read more
asthma-related events and lower risk of asthma exacerbations
compared to Budesonide alone
Read more
Yellow fever outbreak in Congo, Angola bigger than thought - WHO
GENEVA, Aug 31 (Reuters) - Some 6,000 people in Angola and
Democratic Republic of Congo are believed to be infected with
yellow fever, six times the number of confirmed cases, but no
new infections have been confirmed since July 12, the World
Health Organization said on Wednesday.
Read more
Democratic Republic of Congo are believed to be infected with
yellow fever, six times the number of confirmed cases, but no
new infections have been confirmed since July 12, the World
Health Organization said on Wednesday.
Read more
CORRECTED-Alere lawsuit accuses Abbott of 'buyer's remorse' in proposed merger
Aug 31 (Reuters) - Alere Inc alleges Abbott
Laboratories is trying to stymie its planned $5.8
billion takeover of the diagnostics company by purposefully
delaying key submissions to anti-trust regulators, according to
a lawsuit made public on Tuesday.
Read more
Laboratories is trying to stymie its planned $5.8
billion takeover of the diagnostics company by purposefully
delaying key submissions to anti-trust regulators, according to
a lawsuit made public on Tuesday.
Read more
BRIEF-AB Science H1 net loss widens to 14.8 million euros
* H1 net loss of 14.8 million euros versus loss of 13.0 million euros ($14.49 million)
year ago
Read more
year ago
Read more
BRIEF-Ab-Biotics obtains patent for its product Ab-Fortis in Chile
* The patent protects iron-fortified foods and the process of enrichment of foods with iron
Read more
Read more
REFILE-Medical device maker Tecomet up for sale -sources
Aug 31 (Reuters) - Tecomet Inc, a privately held U.S.
contract manufacturer of medical devices and surgical
instruments, is exploring a sale that could value it at more
than $1 billion, including debt, according to people familiar
with the matter.
Read more
contract manufacturer of medical devices and surgical
instruments, is exploring a sale that could value it at more
than $1 billion, including debt, according to people familiar
with the matter.
Read more
BRIEF-NanoRepro appoints Michael Fuchs as CFO
* Appoints Michael Fuchs as CFO
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
Allergan, Adamas settle patent lawsuit with Amneal
Aug 31 (Reuters) - Allergan Plc said it and Adamas
Pharmaceuticals Inc settled a patent infringement
lawsuit with Amneal Pharmaceuticals over their Alzheimer's drug.
Read more
Pharmaceuticals Inc settled a patent infringement
lawsuit with Amneal Pharmaceuticals over their Alzheimer's drug.
Read more
BRIEF-Biotage to invest in biomolecule purification
* Says company invests 15 mln DKK into biomolecule area
through subscription of new shares in Danish company Chreto Aps
Read more
through subscription of new shares in Danish company Chreto Aps
Read more
BRIEF-Jamere Jackson Elected to Lilly board of directors
* Jackson's position prior to joining Nielsen Holdings was
VP and CFO for GE oil & gas, drilling and surface division
Read more
VP and CFO for GE oil & gas, drilling and surface division
Read more
Fitch Updates Parent and Subsidiary Rating Linkage Criteria; No Rating Impact
(The following statement was released by the rating agency)
Link to Fitch Ratings' Report: Parent and Subsidiary Rating
Linkage
https://www.fitchratings.com/site/re/886557
SYDNEY, August 31 (Fitch) Fitch Ratings has updated its "Parent
and Subsidiary
Rating Linkage" criteria, which describes Fitch's approach to
rating entities
within a non-financial corporate group structure.
The changes to the criteria are minor and the update does not
affect existing
ratings.
The updated criteria report is
Read more
Link to Fitch Ratings' Report: Parent and Subsidiary Rating
Linkage
https://www.fitchratings.com/site/re/886557
SYDNEY, August 31 (Fitch) Fitch Ratings has updated its "Parent
and Subsidiary
Rating Linkage" criteria, which describes Fitch's approach to
rating entities
within a non-financial corporate group structure.
The changes to the criteria are minor and the update does not
affect existing
ratings.
The updated criteria report is
Read more
BRIEF-Advanced Health names Carel Petrus Snyman as CFO
* Carel Petrus Snyman has been appointed as chief financial
officer with effect from 31 August 2016.
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +91 80 6749 1136)
Read more
officer with effect from 31 August 2016.
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +91 80 6749 1136)
Read more
MIDEAST STOCKS-Qatar takes a breather, Dubai edges higher
DUBAI, Aug 31 (Reuters) - Gulf stock markets diverged in
early trade on Wednesday, with Qatar's edging lower and Dubai's
gaining slightly.
Read more
early trade on Wednesday, with Qatar's edging lower and Dubai's
gaining slightly.
Read more
BRIEF-Expres2ion Biotech H1 pre-tax loss SEK 2.0 million
* H1 pre-tax loss 2.0 million crowns
Source text for Eikon:
Further company coverage:
($1 = 8.5399 Swedish crowns)
(Gdynia Newsroom)
Read more
Source text for Eikon:
Further company coverage:
($1 = 8.5399 Swedish crowns)
(Gdynia Newsroom)
Read more
BRIEF-Arcoma Q2 EBITDA loss narrows to SEK 3.2 million
* Q2 EBITDA loss 3.2 million Swedish crowns ($375,000)
versus loss 4.5 million crowns year ago
Read more
versus loss 4.5 million crowns year ago
Read more
Tuesday, August 30, 2016
BRIEF-Oncolys BioPharma applies phase II clinical trial of OBP-301 in U.S
* Says it submitted clinical trial plan (protocol) to the
United States Food and Drug Administration for phase II clinical
trial of oncolytic virus OBP-301 (Telomelysin) in U.S
Read more
United States Food and Drug Administration for phase II clinical
trial of oncolytic virus OBP-301 (Telomelysin) in U.S
Read more
BRIEF-Ribomic says substance patent assessment for anti-midkine aptamers in US
* Says co receives substance patent assessment for
anti-midkine aptamers, which is jointly developed with Otsuka
Pharmaceutical Co., Ltd., in US
Read more
anti-midkine aptamers, which is jointly developed with Otsuka
Pharmaceutical Co., Ltd., in US
Read more
BRIEF-Biomerieux 2016 guidance revised to top of range
* H1 net income of consolidated companies 86 million euros ($95.9 million) versus 59 million
euros a year ago
Read more
euros a year ago
Read more
Express Scripts diabetes program aims to cap costs for customers
Aug 31 (Reuters) - Express Scripts Holding, the
largest U.S. pharmacy benefit manager, said on Wednesday it will
implement a program next year that guarantees per-patient
spending caps on diabetes drug costs in an effort to limit
soaring increases for its customers.
Read more
largest U.S. pharmacy benefit manager, said on Wednesday it will
implement a program next year that guarantees per-patient
spending caps on diabetes drug costs in an effort to limit
soaring increases for its customers.
Read more
BRIEF-WooGene B&G receives patent
* Says it receives patent on Aug. 30, for an attenuated
porcine epidemic diarrhea virus, vaccine composition comprising
the same
Read more
porcine epidemic diarrhea virus, vaccine composition comprising
the same
Read more
Theranos withdraws new Zika test after FDA inspection -WSJ
Aug 30 (Reuters) - Blood-testing firm Theranos Inc withdrew
its request for emergency clearance of a Zika-virus blood test
after U.S. regulators found the company did not include proper
patient safeguards in a study on the test, The Wall Street
Journal reported, citing people familiar with the matter.
Read more
its request for emergency clearance of a Zika-virus blood test
after U.S. regulators found the company did not include proper
patient safeguards in a study on the test, The Wall Street
Journal reported, citing people familiar with the matter.
Read more
BRIEF-Xiamen Kingdomway Group expects Q1 to Q3 2016 net profit to increase by 70 to 120 pct
* Says net profit for Q1 to Q3 of 2016 expected to increase
by 70 percent to 120 percent, or to be 189.8 million to 245.6
million yuan
Read more
by 70 percent to 120 percent, or to be 189.8 million to 245.6
million yuan
Read more
BRIEF-USPTO dismisses petition for inter partes review of Fanapt patent
* Uspto dismisses petition for inter partes review of
fanapt patent
Source text for Eikon:
Further company coverage:
Read more
fanapt patent
Source text for Eikon:
Further company coverage:
Read more
UPDATE 1-Study finds flaws in criticism of St. Jude cyber security
(Adds comment from Muddy Waters)
By Ransdell Pierson
Aug 30 (Reuters) - University of Michigan researchers on
Tuesday said their own experiments undermine recent allegations
of security flaws in St. Jude Medical Inc's pacemakers
and other implantable medical devices.
Shares of St. Jude fell 5 percent on Thursday after
short-selling firm Muddy Waters and its business partner, cyber
security company MedSec Holdings Inc, alleged finding
significant security bugs in the company's Merl
Read more
BRIEF-Mimedx provides update on key clinical trials
* Plantar fasciitis ind study receives fda approval for
protocol amendment reducing follow-up requirements by one year
Source text for Eikon:
Further company coverage:
Read more
protocol amendment reducing follow-up requirements by one year
Source text for Eikon:
Further company coverage:
Read more
U.S. senators press Mylan on 'exorbitantly expensive' EpiPen
WASHINGTON, Aug 30 (Reuters) - Democrat Elizabeth Warren and
19 other U.S. senators voiced concern to the chief executive of
Mylan NV about the high cost of its EpiPen on Tuesday,
calling the device used in the case of life-threatening
allergies "exorbitantly expensive."
Read more
19 other U.S. senators voiced concern to the chief executive of
Mylan NV about the high cost of its EpiPen on Tuesday,
calling the device used in the case of life-threatening
allergies "exorbitantly expensive."
Read more
BRIEF-Kewaunee Scientific Q1 earnings per share $0.48
* Order backlog was $86.2 million at July 31, 2016, as
compared to $86.7 million at July 31, 2015
Source text for Eikon:
Further company coverage:
Read more
compared to $86.7 million at July 31, 2015
Source text for Eikon:
Further company coverage:
Read more
AstraZeneca to pay $5.52 mln to resolve U.S. SEC foreign bribery case
NEW YORK, Aug 30 (Reuters) - U.S. regulators said on Tuesday
that AstraZeneca Plc will pay $5.52 million to resolve a
foreign bribery probe into improper payments by its sales and
marketing staff to officials at state-controlled health care
providers in China and Russia.
Read more
that AstraZeneca Plc will pay $5.52 million to resolve a
foreign bribery probe into improper payments by its sales and
marketing staff to officials at state-controlled health care
providers in China and Russia.
Read more
CDC adds Zika-hit Singapore to interim travel guidance list
Aug 30 (Reuters) - The U.S. Centers for Disease Control and
Prevention (CDC) said it had added Singapore to its interim
travel guidance list, following reports of Zika infections in
the country.
Read more
Prevention (CDC) said it had added Singapore to its interim
travel guidance list, following reports of Zika infections in
the country.
Read more
BRIEF-Relypsa says Phase 4 TOURMALINE study meets primary endpoint
* Announces phase 4 study shows veltassa demonstrated
similar efficacy and safety whether given with or without food
in patients with hyperkalemia
Read more
similar efficacy and safety whether given with or without food
in patients with hyperkalemia
Read more
New York expands access to restrictive medical marijuana program
NEW YORK, Aug 30 (Reuters) - New York state will loosen
rules on marijuana prescribing, allow home delivery of the drug
and take other steps to expand its medical cannabis program,
health officials announced on Tuesday.
Read more
rules on marijuana prescribing, allow home delivery of the drug
and take other steps to expand its medical cannabis program,
health officials announced on Tuesday.
Read more
BRIEF-Karyopharm Therapeutics provides update on Phase 2b STORM study
* Intends to expand its Phase 2b storm study evaluating
activity of selinexor in multiple myeloma
Read more
activity of selinexor in multiple myeloma
Read more
BRIEF-Cempra says FDA scheduled meeting to discuss safety, efficacy of solithromycin
* FDA scheduled meeting of Antimicrobial Drugs Advisory
Committee on Nov. 4 to discuss safety, efficacy of solithromycin
Source text for Eikon:
Further company coverage:
Read more
Committee on Nov. 4 to discuss safety, efficacy of solithromycin
Source text for Eikon:
Further company coverage:
Read more
Zika causes deafness in about 6 percent of cases - study
CHICAGO, Aug 30 (Reuters) - A study in Brazil of 70 babies
whose mothers had confirmed Zika infections found that nearly 6
percent had hearing loss, adding a new complication to the list
of ills the virus can cause when women are infected during
pregnancy.
Read more
whose mothers had confirmed Zika infections found that nearly 6
percent had hearing loss, adding a new complication to the list
of ills the virus can cause when women are infected during
pregnancy.
Read more
BRIEF-GIC says Straumann pledged an order for 200 mln francs to repurchase shares
Aug 30 (Reuters) - Gic Private Limited Says Will Keep Around
4.5 Pct Of Straumann Shares After Completing Sale, Subject To A
60
Read more
4.5 Pct Of Straumann Shares After Completing Sale, Subject To A
60
Read more
The Reuters Top 75: A list of Asia's most innovative universities
Aug 30 (Reuters) - The Reuters Top 75: Asia's Most Innovative Universities,
identifies the educational institutions that are doing the most to advance
science, invent new technologies and help drive the global economy. Here are
Asia's most innovative universities:
Rank Name Location
1 Korea Advanced Institute of South Korea
Science & Technology (KAIST)
2 University of Tokyo Japan
3 Seoul National University South Korea
Read more
identifies the educational institutions that are doing the most to advance
science, invent new technologies and help drive the global economy. Here are
Asia's most innovative universities:
Rank Name Location
1 Korea Advanced Institute of South Korea
Science & Technology (KAIST)
2 University of Tokyo Japan
3 Seoul National University South Korea
Read more
Singapore confirms 26 more local transmission Zika cases - media
SINGAPORE, Aug 30 (Reuters) - Singapore confirmed 26 more
cases of locally-transmitted Zika infections on Tuesday,
bringing the tally to 82, local media reported, citing the
health ministry and National Environment Agency.
Read more
cases of locally-transmitted Zika infections on Tuesday,
bringing the tally to 82, local media reported, citing the
health ministry and National Environment Agency.
Read more
BRIEF-Array Biopharma presents data from cardiovascular trial
* Array presents data from cardiovascular trial with
arry-797 at the european society of cardiology congress
Read more
arry-797 at the european society of cardiology congress
Read more
BRIEF-Orexigen Therapeutics announces commercialization and distributorship agreement with Valeant Canada for Contrave
* Orexigen Therapeutics announces commercialization and
distributorship agreement with Valeant Canada for Contrave
(naltrexone hcl / bupropion hcl extended release)
Source text for Eikon:
Further company coverage:
Read more
distributorship agreement with Valeant Canada for Contrave
(naltrexone hcl / bupropion hcl extended release)
Source text for Eikon:
Further company coverage:
Read more
BRIEF-General Electric joins with MIT Energy Initiative
* GE joins with MIT Energy Initiative to develop advanced
technology solutions for transforming global energy systems
Read more
technology solutions for transforming global energy systems
Read more
BRIEF-Kamada meets primary endpoint of U.S. Phase 2 study of inhaled Alpha-1 Antitrypsin
* Kamada meets primary endpoint of U.S. Phase 2 study of
inhaled Alpha-1 Antitrypsin for the treatment of Alpha-1
Antitrypsin deficiency
Read more
inhaled Alpha-1 Antitrypsin for the treatment of Alpha-1
Antitrypsin deficiency
Read more
UPDATE 2-Vectura's therapy misses primary goal in late stage lung disease trial
Aug 30 (Reuters) - Drugmaker Vectura Group Plc said
its asthma therapy Flutiform had not met the primary endpoint in
a late-stage trial to determine its ability to treat COPD, a
type of lung disease, sending the British firm's stock to its
lowest in 21 months.
Read more
its asthma therapy Flutiform had not met the primary endpoint in
a late-stage trial to determine its ability to treat COPD, a
type of lung disease, sending the British firm's stock to its
lowest in 21 months.
Read more
BRIEF-Kangmei Pharmaceutical to set up data information service unit in Shenzhen
* Says it plans to set up data information service unit in
Shenzhen, with registered capital of 50 million yuan
Read more
Shenzhen, with registered capital of 50 million yuan
Read more
BRIEF-Medius Holdings gets approval to upgrade to TSE second section
* Says the co gets approval to upgrade to Tokyo Stock
Exchange (TSE) second section from TSE JASDAQ, effective on Sep.
6
Read more
Exchange (TSE) second section from TSE JASDAQ, effective on Sep.
6
Read more
UPDATE 2-UK Stocks-Factors to watch on Aug 30
Aug 30 (Reuters) - Britain's FTSE 100 index is expected to open
13-18 points, or 0.2-0.3 percent, lower on Tuesday, according to financial
bookmakers, with futures trading down 0.3 percent ahead of the cash
market open.
Read more
13-18 points, or 0.2-0.3 percent, lower on Tuesday, according to financial
bookmakers, with futures trading down 0.3 percent ahead of the cash
market open.
Read more
Monday, August 29, 2016
BRIEF-Bioton appoints temporary CEO
* Said on Monday that the company's supervisory board
member, Marcin Dukaczewski, has been delegated to act as
Bioton's temporary CEO until Nov. 30
Read more
member, Marcin Dukaczewski, has been delegated to act as
Bioton's temporary CEO until Nov. 30
Read more
BRIEF-Cerenis therapeutics completes patient enrolment in CARAT study
* Completion of patient enrolment in the CARAT study - meeting the clinical schedule
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
BRIEF-Naturalendo Tech to issue 5 bln won worth of convertible bonds
* Says it will issue the eighth unregistered/unsecured
private convertible bonds, raising 5 billion won in proceeds for
operations
Read more
private convertible bonds, raising 5 billion won in proceeds for
operations
Read more
BRIEF-Naturalendo Tech appoints Jang Hyeon Wu as CEO
* Says it appoints Jang Hyeon Wu as CEO of the co, to
replace Kim Jae Su, effective from Aug. 30
Read more
replace Kim Jae Su, effective from Aug. 30
Read more
BRIEF-Naturalendo Tech receives patent
* Says it receives patent on Aug. 30, for semiconductor chip
package for image sensor and method for manufacturing thereof
Read more
package for image sensor and method for manufacturing thereof
Read more
BRIEF-Hemostemix voids strategic alliance agreement with Hemostemix Asia Inc
* It has voided a strategic alliance agreement with
Hemostemix Asia Inc
Source text for Eikon:
Further company coverage:
Read more
Hemostemix Asia Inc
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Biotelemetry gets CE mark approval of Holter analysis software
* Received ce mark approval of its holter analysis software
Source text for Eikon:
Further company coverage:
Read more
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Morgan Stanley reports 5 pct passive stake in GenMark Diagnostics as of Aug 17
* Morgan Stanley reports 5.0 percent passive stake in
GenMark Diagnostics Inc as of August 17 -Sec filing
Source text (http://bit.ly/2bvx56E)
Further company coverage:
Read more
GenMark Diagnostics Inc as of August 17 -Sec filing
Source text (http://bit.ly/2bvx56E)
Further company coverage:
Read more
BRIEF-Ann Hanham joins HTG Molecular Diagnostics' board
* Dr. Ann Hanham joins HTG Molecular Diagnostics' board of
directors
Source text for Eikon:
Further company coverage:
Read more
directors
Source text for Eikon:
Further company coverage:
Read more
Fitch: Walgreen/Prime Extends US Pharma Consolidation
(The following statement was released by the rating agency)
CHICAGO/NEW YORK, August 29 (Fitch) Walgreens and Prime
Therapeutics Monday
announced a long-term strategic alliance, highlighting the
continuing
consolidation of the pharmaceutical channel, particularly in the
US, according
to Fitch Ratings.
In the past four years, nearly all major retail and mail-order
pharmacies,
pharmacy benefit managers (PBMs), and pharmaceutical wholesalers
have found
partners to create mega buying groups, p
Read more
CHICAGO/NEW YORK, August 29 (Fitch) Walgreens and Prime
Therapeutics Monday
announced a long-term strategic alliance, highlighting the
continuing
consolidation of the pharmaceutical channel, particularly in the
US, according
to Fitch Ratings.
In the past four years, nearly all major retail and mail-order
pharmacies,
pharmacy benefit managers (PBMs), and pharmaceutical wholesalers
have found
partners to create mega buying groups, p
Read more
BRIEF-U.S. Representatives seek details from Mylan on EpiPens price rise
* Representatives Jason Chaffetz, Elijah Cummings Of U.S.
House Committee On Oversight And Government Reform Send Letter
To Mylan CEO
Read more
House Committee On Oversight And Government Reform Send Letter
To Mylan CEO
Read more
U.S. House Committee requests EpiPen documents from Mylan
Aug 29 (Reuters) - U.S. representatives Jason Chaffetz and
Elijah Cummings of the House Committee on Oversight and
Government Reform sent a letter to Mylan NV Chief
Executive Heather Bresch on Monday asking for documents and
communications related to the fast-increasing price of allergy
auto-injector EpiPens.
Read more
Elijah Cummings of the House Committee on Oversight and
Government Reform sent a letter to Mylan NV Chief
Executive Heather Bresch on Monday asking for documents and
communications related to the fast-increasing price of allergy
auto-injector EpiPens.
Read more
BRIEF-Carmat announces start of pivotal study
* Announces that the first implantation of its bioprosthetic
artificial heart within the framework of the pivotal study has
been carried out in accordance with the authorizations obtained
from the ANSM (French national agency for the safety of
medicines and health products) and CPP (patient protection
committee)
Read more
artificial heart within the framework of the pivotal study has
been carried out in accordance with the authorizations obtained
from the ANSM (French national agency for the safety of
medicines and health products) and CPP (patient protection
committee)
Read more
BRIEF-FDA grants orphan-drug designation for Regenicin's Novaderm cultured skin substitute
* FDA grants drug designation for Regenicin's Novaderm
cultured skin substitute
Source text for Eikon:
Further company coverage:
Read more
cultured skin substitute
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Ramsay Generale de Sante FY revenue 2.2 billion euros
Aug 29 (Reuters) - Ramsay Generale de Sante :
FY reported revenue of new group amounted to 2,226.9
million euros ($2.49 billion)
FY net income amounted to 42.2 million euros
FY reported EBITDA reached 269.8 million euros
Source text for Eikon:
Further company coverage:
($1 = 0.8953 euros)
(Reporting by Daniel Lourenco)
Read more
FY reported revenue of new group amounted to 2,226.9
million euros ($2.49 billion)
FY net income amounted to 42.2 million euros
FY reported EBITDA reached 269.8 million euros
Source text for Eikon:
Further company coverage:
($1 = 0.8953 euros)
(Reporting by Daniel Lourenco)
Read more
BRIEF-Prism medical says court approval granted for deal with Handicare Group AB
* Court approval granted for acquisition of Prism Medical
Ltd. by Handicare Group AB
Source text for Eikon:
Further company coverage:
Read more
Ltd. by Handicare Group AB
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Nymox says new phase 3 long-term U.S.results for fexapotide show major decrease in prostate cancer
* Nymox's new Phase 3 long-term U.S. results for prostate
enlargement drug fexapotide show decrease in prostate cancer
Read more
enlargement drug fexapotide show decrease in prostate cancer
Read more
BRIEF-Farmsintez H1 net result turns to profit of RUB 512.4 million
* H1 net profit 512.4 million roubles ($7.88 million) versus loss of 283.0 million roubles
year ago
Read more
year ago
Read more
Singapore confirms 15 more local transmission Zika cases - media
SINGAPORE, Aug 29 (Reuters) - Singapore confirmed 15 more
cases of locally-transmitted infections with the Zika virus late
on Monday, having announced 41 over the weekend, the Straits
Times newspaper reported, citing the health ministry.
Read more
cases of locally-transmitted infections with the Zika virus late
on Monday, having announced 41 over the weekend, the Straits
Times newspaper reported, citing the health ministry.
Read more
Researchers find first U.S. bacteria with worrisome superbug genes
Aug 29 (Reuters) - New Jersey researchers said on Monday
they had identified perhaps the first strain of E. Coli bacteria
in the United States with mobile genes that make it resistant to
two types of antibiotics now considered last-line defenses
against superbugs.
Read more
they had identified perhaps the first strain of E. Coli bacteria
in the United States with mobile genes that make it resistant to
two types of antibiotics now considered last-line defenses
against superbugs.
Read more
BRIEF-Inovio launches Zika vaccine trial
* Inovio launches Zika vaccine trial in midst of Puerto Rico
epidemic to explore early signals of vaccine efficacy
Read more
epidemic to explore early signals of vaccine efficacy
Read more
BRIEF-Martin Shkreli dissolves stake in Kalobios Pharmaceuticals
* Martin Shkreli - sold all shares of Kalobios
Pharmaceuticals common stock held on Aug 25, 2016 and Aug 26,
2016 in private transactions
Read more
Pharmaceuticals common stock held on Aug 25, 2016 and Aug 26,
2016 in private transactions
Read more
BRIEF-Solco Biomedical to issue 3.5 bln won worth of convertible bonds
* Says it will issue the 10th unregistered/unsecured private
convertible bonds, raising 3.5 billion won in proceeds for
operations
Read more
convertible bonds, raising 3.5 billion won in proceeds for
operations
Read more
Sunday, August 28, 2016
BRIEF-Hunan Hansen Pharmaceutical unit cancels cooperation with maternal and child care service center
* Says its wholly owned health industry subsidiary canceled
cooperation with maternal and child care service center
Read more
cooperation with maternal and child care service center
Read more
BRIEF-Hunan Hansen Pharmaceutical scraps 2015 private placement
Aug 29 (Reuters) - Hunan Hansen Pharmaceutical Co.,
Ltd. :
* Says it scraps 2015 private placement
* Says private placement plan disclosed on Dec. 31, 2015
Source text in Chinese:http://goo.gl/d18pHf
Further company coverage:
(Beijing Headline News)
Read more
UPDATE 1-Singapore confirms 41 cases of locally-transmitted Zika virus
* Singapore cleans drains, sprays insecticide vs mosquitoes
(Adds details, background, related story links)
Read more
(Adds details, background, related story links)
Read more
Singapore confirms 41 cases of locally-transmitted Zika virus - media
SINGAPORE, Aug 28 (Reuters) - Singapore has confirmed 41
cases of locally-transmitted Zika virus, local media reported on
Sunday, citing the city-state's health ministry.
Read more
cases of locally-transmitted Zika virus, local media reported on
Sunday, citing the city-state's health ministry.
Read more
Saturday, August 27, 2016
Singapore confirms first case of locally transmitted Zika virus
SINGAPORE, Aug 28 (Reuters) - Singapore has confirmed its
first case of a locally-transmitted Zika virus, which has been
linked to microcephaly, a rare birth defect, in Brazil, the
health ministry said.
Read more
first case of a locally-transmitted Zika virus, which has been
linked to microcephaly, a rare birth defect, in Brazil, the
health ministry said.
Read more
RPT-Whiplashed investors stay skittish about St. Jude
Aug 26 (Reuters) - One day after a short seller claimed that
St. Jude Medical Inc's heart implants are vulnerable to
deadly cyber attacks, investors appear most concerned about
whether the accusation will derail St. Jude's $24 billion
planned deal for Abbott Labs to buy it.
Read more
St. Jude Medical Inc's heart implants are vulnerable to
deadly cyber attacks, investors appear most concerned about
whether the accusation will derail St. Jude's $24 billion
planned deal for Abbott Labs to buy it.
Read more
CORRECTED-UPDATE 4-FDA recommends Zika testing for all blood donated in U.S.
CHICAGO/TAMPA, Fla., Aug 26 (Reuters) - The U.S. Food and
Drug Administration recommended on Friday that all blood donated
in the United States and its territories be tested for Zika
virus, as it moves to prevent transmission of the virus through
the blood supply.
Read more
Drug Administration recommended on Friday that all blood donated
in the United States and its territories be tested for Zika
virus, as it moves to prevent transmission of the virus through
the blood supply.
Read more
Hong Kong's first suspected Zika case tests negative - radio
HONG KONG, Aug 27 (Reuters) - Hong Kong's first suspected
Zika patient tested negative for the virus and has been
discharged from hospital, broadcaster Radio Television Hong Kong
(RTHK) reported on Saturday.
Read more
Zika patient tested negative for the virus and has been
discharged from hospital, broadcaster Radio Television Hong Kong
(RTHK) reported on Saturday.
Read more
UPDATE 1-Hong Kong's first Zika case tests negative
HONG KONG, Aug 27 (Reuters) - Hong Kong's first Zika patient
tested negative for the virus on Friday and was discharged from
hospital, the government said in a statement.
Read more
tested negative for the virus on Friday and was discharged from
hospital, the government said in a statement.
Read more
Friday, August 26, 2016
BRIEF-CVI Investments Inc reports 9.9 pct passive stake in Enteromedics Inc
* CVI Investments Inc reports 9.9 pct passive stake in
enteromedics inc, as of August 18, 2016 - Sec Filing
Source - http://bit.ly/2cetnP4
Further company coverage:
Read more
enteromedics inc, as of August 18, 2016 - Sec Filing
Source - http://bit.ly/2cetnP4
Further company coverage:
Read more
BRIEF-DexTech proposes rights issue of up to 590,113 shares
* Proposes rights issue of up to 590,113 shares at an issue price of 26.00 Swedish crowns
($3.10) per share
Read more
($3.10) per share
Read more
UPDATE 1-Foreign seed firms team up to oppose new India GM crop rules
NEW DELHI, Aug 26 (Reuters) - Major international seed
companies formed an alliance on Friday to oppose a proposal by
India that would force them to share their genetically modified
crop technology with local players.
Read more
companies formed an alliance on Friday to oppose a proposal by
India that would force them to share their genetically modified
crop technology with local players.
Read more
BRIEF-TG Therapeutics announces orphan drug designation for TG-1101
* TG Therapeutics announces orphan drug designation for
TG-1101 for the treatment of neuromyelitis optica and
neuromyelitis optica spectrum disorder
Source text for Eikon:
Further company coverage:
Read more
TG-1101 for the treatment of neuromyelitis optica and
neuromyelitis optica spectrum disorder
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Aurora Optoelectronics plans share private placement to fund projects, replenish capital
* Says it plans to raise up to 2.0 billion yuan ($299.91
million)in private placement of shares to fund projects,
replenish capital
Read more
million)in private placement of shares to fund projects,
replenish capital
Read more
PRESS DIGEST-Canada - Aug. 26
Aug 26 (Reuters) - The following are the top stories from
selected Canadian newspapers. Reuters has not verified these
stories and does not vouch for their accuracy.
Read more
selected Canadian newspapers. Reuters has not verified these
stories and does not vouch for their accuracy.
Read more
Thursday, August 25, 2016
Swiss stocks - Factors to watch on Aug 26
ZURICH, Aug 26 (Reuters) - The Swiss blue-chip SMI
was seen opening 0.1 percent lower at 8,137 points on Friday,
according to premarket indications by bank Julius Baer
.
Read more
was seen opening 0.1 percent lower at 8,137 points on Friday,
according to premarket indications by bank Julius Baer
.
Read more
BRIEF-Sanochemia Pharmazeutika H1 turnover up 12 pct at 26.68 million euros
* Total turnover was up at 30 June 2016 compared to previous
year by 12 pct to 26.681 million euros (previous year: 23.900
million euros)
Read more
year by 12 pct to 26.681 million euros (previous year: 23.900
million euros)
Read more
PRESS DIGEST - Wall Street Journal - Aug 26
Aug 26 (Reuters) - The following are the top stories in the
Wall Street Journal. Reuters has not verified these stories and
does not vouch for their accuracy.
Read more
Wall Street Journal. Reuters has not verified these stories and
does not vouch for their accuracy.
Read more
PRESS DIGEST- New York Times business news - Aug 26
Aug 26 (Reuters) - The following are the top stories on the
New York Times business pages. Reuters has not verified these
stories and does not vouch for their accuracy.
Read more
New York Times business pages. Reuters has not verified these
stories and does not vouch for their accuracy.
Read more
Lung cancer doctors eye Merck's Keytruda over Bristol's Opdivo
Aug 25 (Reuters) - Recent clinical trial results are likely
to lead doctors to treat more patients who have a common form of
lung cancer with a Merck drug at the expense of a
Bristol-Myers Squibb medication at least until more data
emerges, oncologists and analysts say.
Read more
to lead doctors to treat more patients who have a common form of
lung cancer with a Merck drug at the expense of a
Bristol-Myers Squibb medication at least until more data
emerges, oncologists and analysts say.
Read more
Brazilian police recommend charges against U.S. swimmer Lochte
SAO PAULO, Aug 25 (Reuters) - Brazilian police recommended
on Thursday that prosecutors present charges against Ryan Lochte
for a false crime report, after the U.S. swimmer told police and
media last week that he and three team mates were robbed at
gunpoint during the Rio Olympics.
Read more
on Thursday that prosecutors present charges against Ryan Lochte
for a false crime report, after the U.S. swimmer told police and
media last week that he and three team mates were robbed at
gunpoint during the Rio Olympics.
Read more
BRIEF-Immunogen announces update to financial results year ended June 30, 2016 - SEC filing
* Announces update to financial results for the quarter and
year ended June 30, 2016 - SEC filing
Read more
year ended June 30, 2016 - SEC filing
Read more
BRIEF-Moody's says Teva's loss of two copaxone patents is credit negative
* Moody's on Teva Pharmaceutical - there is no change to
Teva Pharmaceutical Industries LTD Baa2 senior unsecured rating
or stable outlook
Source text for Eikon:
Read more
Teva Pharmaceutical Industries LTD Baa2 senior unsecured rating
or stable outlook
Source text for Eikon:
Read more
BRIEF-Vanda says U.S. District Court ruled Roxane Laboratories infringed certain patents
* U.S. District Court ruled that Roxane Laboratories
infringed U.S. patent nos. RE39,198 and 8,586,610 by submitting
to FDA an ANDA
Source text for Eikon:
Further company coverage:
Read more
infringed U.S. patent nos. RE39,198 and 8,586,610 by submitting
to FDA an ANDA
Source text for Eikon:
Further company coverage:
Read more
Illinois attorney general sues Insys over fentanyl drug marketing
Aug 25 (Reuters) - The Illinois attorney general on Thursday
sued Insys Therapeutics Inc, accusing it of deceptively
marketing and selling an addictive fentanyl-based medication,
intended to treat cancer pain, to doctors for off-label uses.
Read more
sued Insys Therapeutics Inc, accusing it of deceptively
marketing and selling an addictive fentanyl-based medication,
intended to treat cancer pain, to doctors for off-label uses.
Read more
BRIEF-Teladoc says U.S. Patent Office invalidates American Well patent
* Teladoc inc says u.s. Patent office invalidates american
well patent, follows teladoc's victory in federal court
Read more
well patent, follows teladoc's victory in federal court
Read more
BRIEF-Stallergenes H1 net income turns to loss of 39.0 million euros
* H1 sales 78.0 million euros ($88.06 million) versus 183.7
million euros pro forma year ago
Read more
million euros pro forma year ago
Read more
UPDATE 2-GM mustard clears hurdle in India but more remain
* Final decision needed by minister; opposition likely
(Adds environment ministry comment in paragraph 5)
Read more
(Adds environment ministry comment in paragraph 5)
Read more
BRIEF-Mylan NV says enhancing access to EPIPEN auto-injector
* Mylan taking immediate action to further enhance access to
epipen (epinephrine injection, usp) auto-injector
Read more
epipen (epinephrine injection, usp) auto-injector
Read more
BRIEF-Neuroderm initiates patient enrollment in a phase III trial of ND0612l for treatment of Parkinson's disease
* Neuroderm initiates patient enrollment in a phase iii
trial of nd0612l for treatment of parkinson's disease
Read more
trial of nd0612l for treatment of parkinson's disease
Read more
BRIEF-Arena Pharmaceuticals, Eisai receive 'paragraph IV certification'
* Co and Eisai Inc have received a 'paragraph IV
certification' notification with respect to patents for Belviq
Read more
certification' notification with respect to patents for Belviq
Read more
ANA to cancel Boeing 787s flights to fix Rolls-Royce engines
TOKYO, Aug 25 (Reuters) - Japan's biggest carrier, ANA
Holdings said on Thursday it has experienced trouble
with the Rolls-Royce engines powering its Boeing
787 Dreamliners and will schedule some aircraft for servicing
over coming days.
Read more
Holdings said on Thursday it has experienced trouble
with the Rolls-Royce engines powering its Boeing
787 Dreamliners and will schedule some aircraft for servicing
over coming days.
Read more
BRIEF-Swedencare Q2 EBIT decreases to SEK 2.3 mln
* Q2 net sales 11.2 million Swedish crowns ($1.33 million) versus 8.2 million crowns year
ago
Read more
ago
Read more
BRIEF-B-Soft to use 105 mln yuan to jointly set up health insurance company
* Says it will use 105 million yuan to jointly set up a
health insurance company with registered capital of 1 billion
yuan in Hainan
Read more
health insurance company with registered capital of 1 billion
yuan in Hainan
Read more
BRIEF-Senzime to collaborate with Örebro University
* Örebro university has been awarded 11 million Swedish crowns and will together with
Senzime, Sandvik, Techtum and Nanoxis explore why immune system reacts differently in different
people after an operation
Source text: http://bit.ly/2c9nxhP
Further company coverage:
(Gdynia Newsroom)
Read more
Senzime, Sandvik, Techtum and Nanoxis explore why immune system reacts differently in different
people after an operation
Source text: http://bit.ly/2c9nxhP
Further company coverage:
(Gdynia Newsroom)
Read more
BRIEF-PHARMA RESEARCH PRODUCTS signs 7.56 bln won contract with JW Pharmaceutical
* Says it signs a business contract with JW Pharmaceutical
co.,ltd., with contract price of 7.56 billion won
Read more
co.,ltd., with contract price of 7.56 billion won
Read more
Wednesday, August 24, 2016
Swiss stocks - Factors to watch on Aug 25
ZURICH, Aug 25 (Reuters) - The following are some of the
main factors expected to affect Swiss stocks on Thursday:
Read more
main factors expected to affect Swiss stocks on Thursday:
Read more
Novartis announces positive phase III results for MS drug siponimod
ZURICH, Aug 25 (Reuters) - Novartis AG said a
late-stage study showed its oral, once-daily BAF312, or
siponimod, reduced the risk of disability progression in a
severe form of multiple sclerosis.
Read more
late-stage study showed its oral, once-daily BAF312, or
siponimod, reduced the risk of disability progression in a
severe form of multiple sclerosis.
Read more
BRIEF-Medigus files for mixed shelf of up to $20 mln
* Files for mixed shelf of up to $20 million - sec filing
Source text for Eikon:
Further company coverage:
Read more
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Mylan invalidates two of Teva's Copaxone patents
* Mylan invalidates two of Teva's Copaxone 40 mg/ml patents
via U.S. Patent and Trademark Office's Inter Partes Review
proceeding
Read more
via U.S. Patent and Trademark Office's Inter Partes Review
proceeding
Read more
UPDATE 1-Clinton calls for lower price on allergy drug EpiPen
WASHINGTON, Aug 24 (Reuters) - Democratic presidential
candidate Hillary Clinton called on pharmaceutical company Mylan
NV to voluntarily drop the price of its severe allergy
treatment drug EpiPen, which has increased in price by more than
400 percent in the past decade.
Read more
candidate Hillary Clinton called on pharmaceutical company Mylan
NV to voluntarily drop the price of its severe allergy
treatment drug EpiPen, which has increased in price by more than
400 percent in the past decade.
Read more
Scientists hope new test could help contain meningitis outbreaks
LONDON, Aug 24 (Thomson Reuters Foundation) - A test has
been developed that could help diagnose bacterial infections
including meningitis in minutes, but it could take several years
before a cheap testing device is available to developing
countries, scientists said on Wednesday.
Read more
been developed that could help diagnose bacterial infections
including meningitis in minutes, but it could take several years
before a cheap testing device is available to developing
countries, scientists said on Wednesday.
Read more
Clinton calls for reduction in cost of allergy drug EpiPen
WASHINGTON, Aug 24 (Reuters) - Hillary Clinton called on
pharmaceutical company Mylan NV to voluntarily drop the
price of their severe allergy treatment drug EpiPen, which has
increased in price by 400 percent in the past decade.
Read more
pharmaceutical company Mylan NV to voluntarily drop the
price of their severe allergy treatment drug EpiPen, which has
increased in price by 400 percent in the past decade.
Read more
BRIEF-U.S. senators Collins and Mccaskill request information and briefing from Mylan on Epipen pricing within two weeks- CNBC
* U.S. senators Collins and Mccaskill request information
and briefing from Mylan on Epipen pricing within two weeks- CNBC
Read more
and briefing from Mylan on Epipen pricing within two weeks- CNBC
Read more
BRIEF-Biothera Pharmaceuticals expands relationship with Merck
* Biothera pharmaceuticals expands relationship with Merck,
enters collaboration for combination cancer immunotherapy trials
in multiple indications
Source text for Eikon:
Further company coverage:
Read more
enters collaboration for combination cancer immunotherapy trials
in multiple indications
Source text for Eikon:
Further company coverage:
Read more
BRIEF-LifeWatch: Aevis Victoria increases shareholdings in LifeWatch to 10.64%
* Announces that it has been informed by Aevis Victoria SA
of increase of its shareholdings in LifeWatch AG from
4.69% to 10.64%
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
of increase of its shareholdings in LifeWatch AG from
4.69% to 10.64%
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
BRIEF-Evgen Pharma granted orphan drug designation for stabilised sulforaphane
* FDA granted company orphan drug designation for use of
stabilised sulforaphane for treatment of subarachnoid
haemorrhage
Source text for Eikon:
Further company coverage:
Read more
stabilised sulforaphane for treatment of subarachnoid
haemorrhage
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Takara Bio launches fully differentiated, Cellartis hiPS beta cells for research use
* Launch of fully differentiated, Cellartis hiPS beta cells
for research use
Source text for Eikon:
Further company coverage:
Read more
for research use
Source text for Eikon:
Further company coverage:
Read more
BRIEF-TG Therapeutics announces orphan drug designation for TGR-1202 for treatment of chronic lymphocytic leukemia
* TG Therapeutics announces orphan drug designation for
TGR-1202 for treatment of chronic lymphocytic leukemia
Source text for Eikon:
Further company coverage:
Read more
TGR-1202 for treatment of chronic lymphocytic leukemia
Source text for Eikon:
Further company coverage:
Read more
Tuesday, August 23, 2016
BRIEF-Shanghai RAAS Blood Products proposes 2016 H1 dividend payment
* Says controlling shareholder proposed to use additional
paid-in capital to distribute 8 new shares for every 10 shares,
as the dividend payment plan for 2016 H1
Read more
paid-in capital to distribute 8 new shares for every 10 shares,
as the dividend payment plan for 2016 H1
Read more
BRIEF-Beijing Leadman Biochemistry plans clinical laboratory unit with Songyuan government
* Says it plans to set up a new unit in Songyuan, which is
engaged in clinical laboratory, under the support from Songyuan
People's government
Read more
engaged in clinical laboratory, under the support from Songyuan
People's government
Read more
BRIEF-Blueprint Medicines enters into agreement, project schedule with Qiagen
* On August 22, entered into a master collaboration
agreement and a project schedule with Qiagen Manchester Limited
Read more
agreement and a project schedule with Qiagen Manchester Limited
Read more
BRIEF-Valeant enters into amendment, restates credit and guaranty agreement
* On August 23 entered into an amendment to its third
amended and restated credit and guaranty agreement, dated as of
February 13, 2012
Read more
amended and restated credit and guaranty agreement, dated as of
February 13, 2012
Read more
BRIEF-Hartalega Holdings lays off almost 600 people in Q1 - Nikkei
* Hartalega Holdings has fired almost 600 people in a "cost
management exercise", which is close to 10 percent of its
headcount in Q1 - Nikkei
Source text for Eikon:
Read more
management exercise", which is close to 10 percent of its
headcount in Q1 - Nikkei
Source text for Eikon:
Read more
UPDATE 1-Florida announces Zika case hundreds of miles from Miami
CHICAGO, Aug 23 (Reuters) - Florida officials on Tuesday
announced the first case of Zika transmitted by mosquitoes in
Pinellas County, located some 265 miles (425 km) from Miami,
where the first locally transmitted U.S. cases were reported.
Read more
announced the first case of Zika transmitted by mosquitoes in
Pinellas County, located some 265 miles (425 km) from Miami,
where the first locally transmitted U.S. cases were reported.
Read more
Florida announces Zika case hundreds of miles from Miami
CHICAGO, Aug 23 (Reuters) - Florida officials on Tuesday
announced the first case of Zika acquired by local mosquitoes in
Pinellas County, located some 265 miles (425 km) from Miami,
where the first locally transmitted U.S. cases were reported.
Read more
announced the first case of Zika acquired by local mosquitoes in
Pinellas County, located some 265 miles (425 km) from Miami,
where the first locally transmitted U.S. cases were reported.
Read more
Monsanto beats cities' lawsuits over San Francisco Bay pollution
Aug 23 (Reuters) - A federal judge has dismissed lawsuits in
which the California cities of San Jose, Oakland and Berkeley
sought to force Monsanto Co to help pay for reducing PCB
contamination to San Francisco Bay.
Read more
which the California cities of San Jose, Oakland and Berkeley
sought to force Monsanto Co to help pay for reducing PCB
contamination to San Francisco Bay.
Read more
BRIEF-Perrigo - generic version of Suprep oral solution is indicated for treatment of cleansing of colon in preparation for colonoscopy in adults
* Perrigo announces tentative FDA approval for generic
version of Suprep oral solution and confirms patent challenge
for generic version of Mirvaso gel
Read more
version of Suprep oral solution and confirms patent challenge
for generic version of Mirvaso gel
Read more
BRIEF-CEL-SCI announces $5 mln registered direct offering
* Net proceeds of offering will be used for ongoing phase 3
study and general corporate purposes
Read more
study and general corporate purposes
Read more
BRIEF-Brainsway reports revenue growth for third quarter in a row
* Brainsway reports consistent revenue growth for third
quarter in a row and provides company updates
Read more
quarter in a row and provides company updates
Read more
BRIEF-Rite Aid's RediClinic & Hackensack Meridian Health form joint venture to Open Retail-Based, Convenient Care Clinics
* Says Rite Aid's RediClinic and Hackensack Meridian Health
form joint venture to Open Retail-Based, Convenient Care Clinics
Read more
form joint venture to Open Retail-Based, Convenient Care Clinics
Read more
BRIEF-Janssen submits application to EMA to expand use of Darzalex
* Janssen submits application to EMA to expand use of
Darzalex (daratumumab) to include combination with standard of
care regimens
Source text for Eikon:
Further company coverage:
Read more
Darzalex (daratumumab) to include combination with standard of
care regimens
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Genmab announces European regulatory submission for daratumumab
* Genmab announces European regulatory submission for
daratumumab in relapsed multiple myeloma
Read more
daratumumab in relapsed multiple myeloma
Read more
BRIEF-SynCore Biotechnology to issue new shares for development of new drug
* Says it will issue 11.5 million new shares of its common
stock with par value of T$10 per share and issue price at T$30
per share
Read more
stock with par value of T$10 per share and issue price at T$30
per share
Read more
BRIEF-Jiuzhitang plans insurance JV with partners
* Says it plans to invest 130 million yuan to set up an
agricultural insurance JV with Dazheng Investment Group Co Ltd
included 11 firms
Read more
agricultural insurance JV with Dazheng Investment Group Co Ltd
included 11 firms
Read more
WHO emergency committee on yellow fever to meet on Aug 30
GENEVA, Aug 23 (Reuters) - The World Health Organization's
(WHO) emergency committee on deadly yellow fever will meet on
Aug. 30 to review outbreaks in Democratic Republic of Congo and
Angola, a spokesman said on Tuesday, as a major vaccination
campaigns continues.
Read more
(WHO) emergency committee on deadly yellow fever will meet on
Aug. 30 to review outbreaks in Democratic Republic of Congo and
Angola, a spokesman said on Tuesday, as a major vaccination
campaigns continues.
Read more
BRIEF-Dong-A Socio Holdings to raise 177.2 bln won via public offering
* Says it will issue 989,876 shares of common stock with par
value of 5,000 won per share in public offering
Read more
value of 5,000 won per share in public offering
Read more
UPDATE 1-Straumann raises sales growth target after strong first half
* Shares rise to all-time high on increased sales view
(Adds share price, CEO, analyst comment, dateline)
Read more
(Adds share price, CEO, analyst comment, dateline)
Read more
UPDATE 1-UK Stocks-Factors to watch on August 23
Aug 23 (Reuters) - Britain's FTSE 100 index is seen opening up 24 to
28 points, or 0.4 percent, on Tuesday, according to financial bookmakers, with
futures up 0.5 percent ahead of the cash market open.
Read more
28 points, or 0.4 percent, on Tuesday, according to financial bookmakers, with
futures up 0.5 percent ahead of the cash market open.
Read more
Monday, August 22, 2016
UK Stocks-Factors to watch on August 23
Aug 23 (Reuters) - Britain's FTSE 100 index is seen opening up 24 to
28 points, or 0.4 percent, on Tuesday, according to financial bookmakers.
* The UK blue chip index closed down 0.4 percent, or 6,828.54 points, on
Monday, with commodity-related stocks leading the market lower following a drop
in metals and crude oil prices.
* RANK GROUP: Casino operator Rank Group Plc said on Tuesday
Britain's decision to leave the European Union would have little or no direct
impact on its perfo
Read more
28 points, or 0.4 percent, on Tuesday, according to financial bookmakers.
* The UK blue chip index closed down 0.4 percent, or 6,828.54 points, on
Monday, with commodity-related stocks leading the market lower following a drop
in metals and crude oil prices.
* RANK GROUP: Casino operator Rank Group Plc said on Tuesday
Britain's decision to leave the European Union would have little or no direct
impact on its perfo
Read more
BRIEF-Straumann H1 revenue up at CHF 461 million
* H1 revenue rises 15% in local currencies and 16% in Swiss
francs to 461 million Swiss francs ($479.56 million)
Read more
francs to 461 million Swiss francs ($479.56 million)
Read more
DIARY-Malaysia 2016 corporate earnings
Following is a list of release dates for the quarterly earnings
of some top Malaysia-listed companies.
To submit a date, email: ananthalakshmi.as@tr.com
TBD: To be determined
Company RIC PERIOD DATE
AirAsia Bhd Q2 Aug 29
AirAsia X Bhd Q2 Aug 23
AMMB Holdings Bhd Q1 Aug 22
Astro Malaysia Holdings Bhd Q2 Sept 13-19
Axiata G
Read more
of some top Malaysia-listed companies.
To submit a date, email: ananthalakshmi.as@tr.com
TBD: To be determined
Company RIC PERIOD DATE
AirAsia Bhd Q2 Aug 29
AirAsia X Bhd Q2 Aug 23
AMMB Holdings Bhd Q1 Aug 22
Astro Malaysia Holdings Bhd Q2 Sept 13-19
Axiata G
Read more
BRIEF-Yantai Dongcheng Biochemicals to pay 2016 H1 dividend on Aug. 30
Aug 23 (Reuters) - Yantai Dongcheng Biochemicals Co Ltd
:
* Says it will pay 2016 H1 dividend on Aug. 30
Source text in Chinese:http://goo.gl/4VNw0B
Further company coverage:
(Beijing Headline News)
Read more
BRIEF-Medtronic reports a passive stake of 8.6 pct in Mazor Robotics
* Medtronic Plc reports a passive stake of 8.6 pct in Mazor
Robotics Ltd as of August 11, 2016 - SEC filing
Source text for Eikon:
Further company coverage:
Read more
Robotics Ltd as of August 11, 2016 - SEC filing
Source text for Eikon:
Further company coverage:
Read more
REFILE-UPDATE 1-Cinven to acquire pharmaceutical research firm Bioclinica
Aug 22 (Reuters) - Cinven Ltd said on Monday it agreed to
acquire BioClinica Inc from two other buyout firms, Water Street
Healthcare Partners and JLL Partners, in a deal that sources
said values the U.S. clinical trials company at around $1.4
billion, including debt.
Read more
acquire BioClinica Inc from two other buyout firms, Water Street
Healthcare Partners and JLL Partners, in a deal that sources
said values the U.S. clinical trials company at around $1.4
billion, including debt.
Read more
U.S. lawmakers press Mylan on EpiPen price increases
WASHINGTON, Aug 22 (Reuters) - Two senior lawmakers on the
U.S. Senate's Judiciary Committee on Monday pushed for
information regarding sharp price increases for EpiPens,
drug-filled injectable devices used by people to counter
potentially deadly allergic reactions.
Read more
U.S. Senate's Judiciary Committee on Monday pushed for
information regarding sharp price increases for EpiPens,
drug-filled injectable devices used by people to counter
potentially deadly allergic reactions.
Read more
BRIEF-Helsinn Investment Fund reports 7.1 pct passive stake in MEI Pharma - SEC filing
* Helsinn Investment Fund SA reports 7.1 pct passive stake
in MEI Pharma Inc as of Aug. 16 - SEC filing
Source text (http://bit.ly/2bxhh2P)
Further company coverage:
Read more
in MEI Pharma Inc as of Aug. 16 - SEC filing
Source text (http://bit.ly/2bxhh2P)
Further company coverage:
Read more
Mislabeled pills seized at Prince's home after his death - reports
Aug 22 (Reuters) - Mislabeled pills were seized at the home
of musician Prince after his death from an overdose of the
powerful opioid fentanyl, according to media reports on Monday.
Read more
of musician Prince after his death from an overdose of the
powerful opioid fentanyl, according to media reports on Monday.
Read more
General Electric to submit bid for Areva's Adwen on Aug. 24 - media
PARIS, Aug 22 (Reuters) - General Electric plans to
submit a bid as early as Thursday to acquire French wind power
group Adwen, jointly owned by Spain's Gamesa and
France's Areva, weekly magazine La Lettre de
l'Expansion reported on Monday.
Read more
submit a bid as early as Thursday to acquire French wind power
group Adwen, jointly owned by Spain's Gamesa and
France's Areva, weekly magazine La Lettre de
l'Expansion reported on Monday.
Read more
BRIEF-Gilead Sciences - European Commission grants marketing authorization for Truvada
* European Commission grants marketing authorization for
Gilead's once-daily Truvada for reducing the risk of sexually
acquired HIV-1
Read more
Gilead's once-daily Truvada for reducing the risk of sexually
acquired HIV-1
Read more
BRIEF-MiMedx says its amniotic allografts are terminally sterilized to enhance safety related to microbiological, viral transmission
* Mimedx group inc says "amniotic allografts are terminally
sterilized to enhance safety related to microbiological and
viral transmission"
Read more
sterilized to enhance safety related to microbiological and
viral transmission"
Read more
REFILE-UPDATE 2-Pfizer boosts cancer drug pipeline with $14 bln Medivation deal
Aug 22 (Reuters) - Pfizer Inc said on Monday it
would buy U.S. cancer drug company Medivation Inc in a
deal valued at about $14 billion, adding blockbuster prostate
cancer drug Xtandi to its portfolio.
Read more
would buy U.S. cancer drug company Medivation Inc in a
deal valued at about $14 billion, adding blockbuster prostate
cancer drug Xtandi to its portfolio.
Read more
BRIEF-Presbia acquires patent portfolio for Presbia Flexivue Microlens
* Presbia acquires comprehensive patent portfolio for
Presbia Flexivue Microlens
Source text for Eikon:
Further company coverage:
Read more
Presbia Flexivue Microlens
Source text for Eikon:
Further company coverage:
Read more
Sanofi says talked with Medivation, but will be "disciplined" acquirer
PARIS, Aug 22 (Reuters) - French pharmaceutical group Sanofi
reacted to Pfizer's roughly $14 billion cash deal for
Medivation Inc by saying it had appreciated the chance
to engage in talks with Medivation in past weeks.
Read more
reacted to Pfizer's roughly $14 billion cash deal for
Medivation Inc by saying it had appreciated the chance
to engage in talks with Medivation in past weeks.
Read more
BRIEF-Humanwell Healthcare's shares to halt trade pending private placement
* Says shares to halt trading from aug 23 pending
announcement related to share private placement
Read more
announcement related to share private placement
Read more
BRIEF-Guangxi Wuzhou Zhongheng to buy shares in Sealand Securities for up to 500 mln yuan
* Says it plans to buy shares in Sealand Securities Co Ltd
for up to 500 million yuan ($75.15 million)
Read more
for up to 500 million yuan ($75.15 million)
Read more
BRIEF-Lilly and Astrazeneca receive FDA fast track designation for AZD3293
* Lilly and Astrazeneca receive FDA fast track designation
for AZD3293, an investigational treatment for early Alzheimer's
disease
Read more
for AZD3293, an investigational treatment for early Alzheimer's
disease
Read more
BRIEF-Shenzhen Neptunus Bioengineering to acquire stake in pharma firm
* Says it signs framework agreement to acquire 70 percent
stake in pharma firm for up to 120 million yuan ($18.03
million)
Read more
stake in pharma firm for up to 120 million yuan ($18.03
million)
Read more
Sunday, August 21, 2016
Actelion completes first-line share purchase program
ZURICH, Aug 22 (Reuters) - Swiss biotech company Actelion
has completed its first-line share purchase programme
which represented more than 8 percent of its shares, it said on
Monday.
Read more
has completed its first-line share purchase programme
which represented more than 8 percent of its shares, it said on
Monday.
Read more
BRIEF-Online part of Autobio's IPO attracts interest amounting to 6030.2 times amount on offer
* Says online part of Shanghai IPO attracted interest
amounting to 6030.2 times amount on offer
Read more
amounting to 6030.2 times amount on offer
Read more
UPDATE 1-Pfizer nears deal to acquire Medivation for close to $14 bln -sources
Aug 21 (Reuters) - Pfizer Inc is in advanced talks
to acquire U.S. cancer drug company Medivation Inc for
close to $14 billion, as it seeks to boost its oncology
portfolio, people familiar with the matter said on Sunday.
Read more
to acquire U.S. cancer drug company Medivation Inc for
close to $14 billion, as it seeks to boost its oncology
portfolio, people familiar with the matter said on Sunday.
Read more
D.A. Henderson, who led effort to eradicate smallpox, dies at 87
Aug 21 (Reuters) - Donald A. Henderson, who headed the World
Health Organization vaccination effort that wiped out smallpox
in 1977 and later became a U.S. bioterrorism expert, has died
from complications following a hip fracture, officials said on
Sunday. He was 87.
Read more
Health Organization vaccination effort that wiped out smallpox
in 1977 and later became a U.S. bioterrorism expert, has died
from complications following a hip fracture, officials said on
Sunday. He was 87.
Read more
Health official warns Zika could spread across U.S. Gulf
Aug 21 (Reuters) - One of the top U.S. public health
officials on Sunday warned that the mosquito-borne Zika virus
could extend its reach across the U.S. Gulf Coast after
officials last week confirmed it as active in the popular
tourist destination of Miami Beach.
Read more
officials on Sunday warned that the mosquito-borne Zika virus
could extend its reach across the U.S. Gulf Coast after
officials last week confirmed it as active in the popular
tourist destination of Miami Beach.
Read more
China over-reliant on hospitals, needs more family doctors: WHO
SHANGHAI, Aug 20 (Reuters) - China's healthcare system is
overly reliant on large, over-burdened hospitals, which will
struggle to cope with a spike in diseases linked to the
fast-ageing population, the World Health Organization said on
Saturday.
Read more
overly reliant on large, over-burdened hospitals, which will
struggle to cope with a spike in diseases linked to the
fast-ageing population, the World Health Organization said on
Saturday.
Read more
Friday, August 19, 2016
BRIEF-Xbiotech files for stock shelf of upto 7 mln shares
* Files for stock shelf of up to 7 million common shares -
SEC filing
Source text: http://bit.ly/2bDqhQ3
Further company coverage:
Read more
SEC filing
Source text: http://bit.ly/2bDqhQ3
Further company coverage:
Read more
BRIEF-Tang Capital Partners Lp says 9.6 pct stake in Cyclacel Pharmaceuticals
* Tang Capital Partners Lp reports 9.6 pct passive stake in
Cyclacel Pharmaceuticals Inc as of Aug 12 - SEC Filing
Source text: http://bit.ly/2bDrkjc
Further company coverage:
Read more
Cyclacel Pharmaceuticals Inc as of Aug 12 - SEC Filing
Source text: http://bit.ly/2bDrkjc
Further company coverage:
Read more
BRIEF-Thar Pharmaceuticals files for IPO of up to $50 million
* Applied to have common stock listed on the Nasdaq Global
Market under the trading symbol "THAR" - SEC filing
Source text for Eikon:
Read more
Market under the trading symbol "THAR" - SEC filing
Source text for Eikon:
Read more
UPDATE 2-Florida governor confirms Zika transmission in Miami Beach
MIAMI, Aug 19 (Reuters) - Florida officials said on Friday
they have identified a new area of Zika virus transmission
through local mosquitoes in a small area in Miami Beach, the
second area in Miami-Dade county where the Zika virus is
spreading.
Read more
they have identified a new area of Zika virus transmission
through local mosquitoes in a small area in Miami Beach, the
second area in Miami-Dade county where the Zika virus is
spreading.
Read more
BRIEF-Supernus Pharma receives FDA tentative approval for expanded label of Trokendi XR
* Supernus receives FDA tentative approval for expanded
label of Trokendi XR to include migraine prophylaxis in adults
Read more
label of Trokendi XR to include migraine prophylaxis in adults
Read more
Polish athlete puts Olympic medal up for sale to help boy with cancer
WARSAW, Aug 19 (Reuters) - Polish discus thrower Piotr
Malachowski has put up for sale the silver medal he won at the
Rio Olympics to help raise funds for a boy with a rare cancer,
the athlete said on Friday.
Read more
Malachowski has put up for sale the silver medal he won at the
Rio Olympics to help raise funds for a boy with a rare cancer,
the athlete said on Friday.
Read more
RPT-Polish athlete puts Olympic medal up for sale to help boy with cancer
WARSAW, Aug 19 (Reuters) - Polish discus thrower Piotr Malachowski has put up for sale the silver medal he won at the Rio Olympics to help raise funds for a boy with a rare cancer, the athlete said on Friday.
Read more
Read more
Investor resistance to Triple C risk crumbles
NEW YORK, Aug 19 (IFR) - Resistance is futile for some
investors eyeing risky Triple C bonds as spreads and absolute
returns continue to tighten across the board.
Read more
investors eyeing risky Triple C bonds as spreads and absolute
returns continue to tighten across the board.
Read more
BRIEF-Johnson & Johnson reports 15 pct passive stake in Protagonist Therapeutics - SEC filing
* Johnson & Johnson reports 15.0 pct passive stake in
Protagonist Therapeutics Inc as of Aug. 16
Source text (http://bit.ly/2biMrcb)
Further company coverage:
Read more
Protagonist Therapeutics Inc as of Aug. 16
Source text (http://bit.ly/2biMrcb)
Further company coverage:
Read more
Deals of the day-Mergers and acquisitions
Aug 19 (Reuters) - The following bids, mergers, acquisitions
and disposals were reported by 1320 GMT on Friday:
Read more
and disposals were reported by 1320 GMT on Friday:
Read more
LPC: Growing loan pipeline suggests post-Labor Day M&A
NEW YORK, Aug 19 (Reuters) - A growing pipeline of deals
buoyed by rising chief executive confidence, a stronger
consensus about interest rate hikes and an abundance of
available capital point to a post-Labor Day pickup in
M&A-related leveraged loan issuance, according to bankers.
Read more
buoyed by rising chief executive confidence, a stronger
consensus about interest rate hikes and an abundance of
available capital point to a post-Labor Day pickup in
M&A-related leveraged loan issuance, according to bankers.
Read more
REFILE-Cambridge University innovation investor raises 75 million pounds
LONDON, Aug 19 (Reuters) - Cambridge Innovation Capital,
which commercializes technology and healthcare research from
Cambridge University, has raised 75 million pounds ($98 million)
from investors, including for the first time Woodford Investment
Management.
Read more
which commercializes technology and healthcare research from
Cambridge University, has raised 75 million pounds ($98 million)
from investors, including for the first time Woodford Investment
Management.
Read more
BRIEF-Biolytical Laboratories says announces patent filings in U.S. for Zika detection assays
* Biolytical Laboratories says announces patent filings in
U.S. for Zika detection assays
Source text for Eikon:
Read more
U.S. for Zika detection assays
Source text for Eikon:
Read more
BRIEF-Spectral expects to release primary end point results for pivotal Euphrates after end of Q3
* Expects to release primary end point results for pivotal
Euphrates trial immediately after end of Q3 ended September 30,
2016
Read more
Euphrates trial immediately after end of Q3 ended September 30,
2016
Read more
BRIEF-Tibet Rhodiola Pharma cuts share issue size to 1.36 bln yuan
* Says it cuts share issue size to 1.36 billion yuan
($204.44 million) from 1.50 billion yuan previously
Read more
($204.44 million) from 1.50 billion yuan previously
Read more
BRIEF-Hengkang Medical plans Chinese medicine institute in Iran
* Says it signs letter of intent to set up Chinese medicines
institute, plant and medical centre in Iran
Read more
institute, plant and medical centre in Iran
Read more
BRIEF-Tianjin Ringpu Bio-technology raises about 229 mln yuan via private placement
* Says it issued 15,347,182 shares at 14.92 yuan per share
and raised about 229 million yuan via private placement
Read more
and raised about 229 million yuan via private placement
Read more
BRIEF-Ambu Q3 EBIT up at DKK 94 million, lifts FY outlook
* Q3 2015/16 revenue 517 million Danish crowns ($78.75 million) versus 482 million crowns
year ago
Read more
year ago
Read more
Thursday, August 18, 2016
BRIEF-Shandong Jincheng Pharmaceutical unit to set up biotechnology JV
* Says its subsidiary will use 2.8 million yuan to set up a
biotechnology JV in Beijing with a Beijing-based biotechnology
company
Read more
biotechnology JV in Beijing with a Beijing-based biotechnology
company
Read more
U.S. judge permanently blocks Florida law to end abortion funding
Aug 18 (Reuters) - A federal judge on Thursday permanently
blocked parts of a Florida law that aimed to cut off state
funding for preventive health services at clinics that also
provide abortions.
Read more
blocked parts of a Florida law that aimed to cut off state
funding for preventive health services at clinics that also
provide abortions.
Read more
Toshiba Medical joins bid to by Takeda unit-Nikkei
TOKYO, Aug 19 (Reuters) - Toshiba Medical Systems, a medical
equipment company that is being bought by Canon Inc,
joined a race to buy a subsidiary of Takeda Pharmaceutical Co
, the Nikkei business daily reported on Friday.
Read more
equipment company that is being bought by Canon Inc,
joined a race to buy a subsidiary of Takeda Pharmaceutical Co
, the Nikkei business daily reported on Friday.
Read more
DIARY-Malaysia 2016 corporate earnings
Following is a list of release dates for the quarterly earnings
of some top Malaysia-listed companies.
To submit a date, email: ananthalakshmi.as@tr.com
TBD: To be determined
Company RIC PERIOD DATE
AirAsia Bhd Q2 Aug 29
AirAsia X Bhd Q2 Aug 23
AMMB Holdings Bhd Q1 Aug 18-22
Astro Malaysia Holdings Bhd Q2 Sept 13-19
Axiat
Read more
of some top Malaysia-listed companies.
To submit a date, email: ananthalakshmi.as@tr.com
TBD: To be determined
Company RIC PERIOD DATE
AirAsia Bhd Q2 Aug 29
AirAsia X Bhd Q2 Aug 23
AMMB Holdings Bhd Q1 Aug 18-22
Astro Malaysia Holdings Bhd Q2 Sept 13-19
Axiat
Read more
UPDATE 1-U.S. fund investors look abroad as rate hike fears ease
(Recasts; Adds details on mutual funds and ETFs, analyst quote,
table, byline)
By Trevor Hunnicutt
NEW YORK, Aug 18 (Reuters) - U.S. investors showed more
confidence putting new money into international markets in the
weekly period through Aug. 17, Lipper data showed on Thursday,
pumping $2.7 billion into emerging-market stock funds.
The funds took in their seventh straight week of cash as
minutes from the U.S. Federal Reserve's July policy meeting
showed its leaders agree that mo
Read more
UPDATE 3-Locally transmitted Zika virus identified in Miami Beach -source
Aug 18 (Reuters) - Florida health officials have found
evidence of local Zika virus transmission in Miami Beach, one of
the world's most popular tourist destinations, opening a new
front in the fight against the mosquito-borne virus, according
to a source familiar with the investigation.
Read more
evidence of local Zika virus transmission in Miami Beach, one of
the world's most popular tourist destinations, opening a new
front in the fight against the mosquito-borne virus, according
to a source familiar with the investigation.
Read more
BRIEF-AGTC appoints Anne Vanlent to board
* AGTC appoints Anne M. Vanlent to its board of directors
Source text for Eikon:
Further company coverage:
Read more
Source text for Eikon:
Further company coverage:
Read more
UPDATE 1-Uber buys self-driving truck startup Otto; teams with Volvo
Aug 18 (Reuters) - Ride service Uber Technologies Inc said
on Thursday it acquired self-driving trucks startup Otto and
formed a $300 million alliance with Volvo Car Group to develop
self-driving cars.
Read more
on Thursday it acquired self-driving trucks startup Otto and
formed a $300 million alliance with Volvo Car Group to develop
self-driving cars.
Read more
Zika virus identified in Miami Beach -Miami Herald
Aug 18 (Reuters) - The Zika virus has been identified in
Miami Beach, opening a new front in the battle against the
virus, the Miami Herald reported on Thursday, citing people
familiar with discussions between state and local health
officials.
Read more
Miami Beach, opening a new front in the battle against the
virus, the Miami Herald reported on Thursday, citing people
familiar with discussions between state and local health
officials.
Read more
BRIEF-FDA approves expanded indication for Sapien XT and Sapien 3 transcatheter heart valves
* U.S. Food and Drug Administration today approved an
expanded indication for the Sapien XT and Sapien 3 transcatheter
heart valves
Read more
expanded indication for the Sapien XT and Sapien 3 transcatheter
heart valves
Read more
Fatherhood inspires U.S. singer Aloe Blacc to star in malaria-themed music video
LONDON, Aug 18 (Thomson Reuters Foundation) - U.S.
singer-songwriter Aloe Blacc said on Thursday that the world
must pay more attention to malaria ahead of launching a music
video focusing on the disease - one of the biggest killers of
children worldwide.
Read more
singer-songwriter Aloe Blacc said on Thursday that the world
must pay more attention to malaria ahead of launching a music
video focusing on the disease - one of the biggest killers of
children worldwide.
Read more
British Ebola nurse 'concealed temperature' on return from Sierra Leone - media
LONDON, Aug 18 (Thomson Reuters Foundation) - A Scottish
nurse who contracted then recovered from Ebola is facing
disciplinary action over allegations she concealed her
temperature on her return from Sierra Leone, according to
charges from a nursing watchdog seen by British media.
Read more
nurse who contracted then recovered from Ebola is facing
disciplinary action over allegations she concealed her
temperature on her return from Sierra Leone, according to
charges from a nursing watchdog seen by British media.
Read more
UPDATE 1-T. Rowe Price sues Valeant over "fraudulent scheme"
Aug 18 (Reuters) - T. Rowe Price Group Inc has sued
Valeant Pharmaceuticals International Inc ,
alleging that investors in the Canadian drugmaker lost billions
of dollars as a result of the company's "fraudulent scheme".
Read more
Valeant Pharmaceuticals International Inc ,
alleging that investors in the Canadian drugmaker lost billions
of dollars as a result of the company's "fraudulent scheme".
Read more
Uber buys self-driving truck startup Otto; teams up with Volvo
Aug 18 (Reuters) - Ride service Uber Technologies Inc said
on Thursday it has acquired the self-driving trucks startup
Otto, and it also announced that Volvo Car Group has agreed to a
$300 million alliance to develop self-driving cars.
Read more
on Thursday it has acquired the self-driving trucks startup
Otto, and it also announced that Volvo Car Group has agreed to a
$300 million alliance to develop self-driving cars.
Read more
BRIEF-Kadimastem signs agreement with medical device co to expand joint trials of diabetes therapy
* Kadimastem signed agreement with medical device company to
expand joint trials of diabetes therapy using unique
encapsulation device
Source text for Eikon:
Further company coverage:
Read more
expand joint trials of diabetes therapy using unique
encapsulation device
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Quest Diagnostics approved to use electronic drug test process for federally-mandated workforce by U.S. Health and Human Services
* Quest Diagnostics approved to use electronic drug test
process for federally-mandated workforce by U.S. Health and
Human Services
Read more
process for federally-mandated workforce by U.S. Health and
Human Services
Read more
BRIEF-Milestone Scientific says distribution deal with Mila International
* Milestone Scientific announces distribution agreement with
Mila International to market and distribute a novel instrument
for equine maxillary nerve blocks
Source text for Eikon:
Further company coverage:
(Bangalore.newsroom@thomsonreuters.com)
Read more
Mila International to market and distribute a novel instrument
for equine maxillary nerve blocks
Source text for Eikon:
Further company coverage:
(Bangalore.newsroom@thomsonreuters.com)
Read more
LPC: Valeant lenders agree to loan amendment to loosen covenants
NEW YORK, Aug 18 (Reuters) - Valeant Pharmaceuticals
International lenders agreed to an amendment to loosen
the company's covenants on its $31 billion of debt, according to
a news release Thursday.
Read more
International lenders agreed to an amendment to loosen
the company's covenants on its $31 billion of debt, according to
a news release Thursday.
Read more
BRIEF-Nightingale Informatix- Cease trade order from Ontario Securities Commission revoked
* Cease trade order issued by Ontario Securities Commission
dated August 5, 2016, has been revoked
Read more
dated August 5, 2016, has been revoked
Read more
BRIEF-Chembio enters into exclusive agreement with Isla Lab
* Chembio expands product distribution through exclusive
agreement with Isla Lab in the Caribbean
Read more
agreement with Isla Lab in the Caribbean
Read more
UPDATE 1-Volvo and Uber team up to develop self-driving cars
STOCKHOLM, Aug 18 (Reuters) - Volvo Car Group has agreed a
$300 million alliance with Uber to develop self-driving cars,
the latest move by traditional vehicle manufacturers to team up
with Silicon Valley firms seen as threats to their industry.
Read more
$300 million alliance with Uber to develop self-driving cars,
the latest move by traditional vehicle manufacturers to team up
with Silicon Valley firms seen as threats to their industry.
Read more
Volvo and Uber team up to develop self-driving cars
STOCKHOLM, Aug 18 (Reuters) - Volvo Car Group has agreed a
$300 million alliance with Uber to develop self-driving cars,
the latest move by traditional vehicle manufacturers to team up
with Silicon Valley firms long seen as disruptive threats to
their industry.
Read more
$300 million alliance with Uber to develop self-driving cars,
the latest move by traditional vehicle manufacturers to team up
with Silicon Valley firms long seen as disruptive threats to
their industry.
Read more
BRIEF-Insys Therapeutics says enrollment of first patient in phase II trial for treatment of cocaine dependence
* Insys therapeutics announces first patient enrolled in
phase ii trial for the treatment of cocaine dependence using
pharmaceutical cannabidiol
Source text for Eikon:
Further company coverage:
Read more
phase ii trial for the treatment of cocaine dependence using
pharmaceutical cannabidiol
Source text for Eikon:
Further company coverage:
Read more
UPDATE 1-Britain launches soft drinks sugar tax to fight obesity
LONDON, Aug 18 (Reuters) - Britain on Thursday said it would
tax companies which sell sugary soft drinks and invest that
money in health programmes for school children, part of a
long-awaited strategy to curb childhood obesity that critics say
is too weak.
Read more
tax companies which sell sugary soft drinks and invest that
money in health programmes for school children, part of a
long-awaited strategy to curb childhood obesity that critics say
is too weak.
Read more
Wednesday, August 17, 2016
UPDATE 1-ResMed seeks patent injunction on Fisher & Paykel Healthcare
WELLINGTON, Aug 18 (Reuters) - ResMed Inc said on
Thursday it has filed legal action to stop the alleged
infringement of its patented technology by New Zealand-based
medical device manufacturer Fisher & Paykel Healthcare.
Read more
Thursday it has filed legal action to stop the alleged
infringement of its patented technology by New Zealand-based
medical device manufacturer Fisher & Paykel Healthcare.
Read more
BRIEF-Retrophin considering acquisition of Raptor Pharmaceutical- Bloomberg
* Retrophin Inc considering acquisition of Raptor
Pharmaceutical Corp - Bloomberg, citing sources
Source text : http://bloom.bg/2boJgAj
Read more
Pharmaceutical Corp - Bloomberg, citing sources
Source text : http://bloom.bg/2boJgAj
Read more
ResMed files legal action against Fisher & Paykel Healthcare
WELLINGTON, Aug 18 (Reuters) - ResMed Inc said on
Thursday it has filed legal action to stop the alleged
infringement of its patented technology by New Zealand-based
medical device manufacturer Fisher & Paykel Healthcare.
Read more
Thursday it has filed legal action to stop the alleged
infringement of its patented technology by New Zealand-based
medical device manufacturer Fisher & Paykel Healthcare.
Read more
BRIEF-Highbridge Capital Management reports 5.3 pct passive stake in Healthsouth Corp
* Highbridge Capital Management LLC reports 5.3 percent
passive stake in Healthsouth Corp as of Aug 10, 2016 - SEC
filing
Source text for Eikon:
Further company coverage:
Read more
passive stake in Healthsouth Corp as of Aug 10, 2016 - SEC
filing
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Sagent Pharma says initiates a nationwide voluntary recall of one lot of Oxacillin
* Sagent pharmaceuticals initiates a nationwide voluntary
recall of oxacillin for injection, usp, 10 g due to presence of
iron oxide particulate matter
Read more
recall of oxacillin for injection, usp, 10 g due to presence of
iron oxide particulate matter
Read more
Guatemala confirms first case of newborn with microcephaly linked to Zika
GUATEMALA CITY, Aug 17 (Reuters) - Guatemalan authorities on
Wednesday confirmed the Central American country's first case of
a baby born with microcephaly linked to Zika.
Read more
Wednesday confirmed the Central American country's first case of
a baby born with microcephaly linked to Zika.
Read more
WHO appoints former NY mayor Bloomberg as global health ambassador
LONDON, Aug 17 (Reuters) - The World Health Organization
(WHO) on Wednesday appointed the philanthropist and former mayor
of New York Michael Bloomberg as a global health ambassador to
help governments tackle chronic diseases such as diabetes,
stroke, cancer and heart disease.
Read more
(WHO) on Wednesday appointed the philanthropist and former mayor
of New York Michael Bloomberg as a global health ambassador to
help governments tackle chronic diseases such as diabetes,
stroke, cancer and heart disease.
Read more
BRIEF-Johnson & Johnson announces ruling related to Remicade
* Johnson & Johnson announces ruling related to Remicade in
the District of Massachusetts Federal Court hearing
Read more
the District of Massachusetts Federal Court hearing
Read more
BRIEF-Quidel gets FDA clearance for Solana Trichomonas assay
* Quidel receives FDA clearance for its Solana Trichomonas
assay for diagnosis of trichomoniasis
Read more
assay for diagnosis of trichomoniasis
Read more
BRIEF-Madison Square Garden- Acquires 12 percent stake in Townsquare
* Acquires 12 percent stake in Townsquare; Purchased about
3.2 million shares of GE Capital's class C common stock in
private transaction
Read more
3.2 million shares of GE Capital's class C common stock in
private transaction
Read more
UPDATE 2-Ex-Wall Street banker convicted for giving father insider tips
NEW YORK, Aug 17 (Reuters) - An ex-Wall Street investment
banker was convicted on Wednesday of engaging in insider trading
by tipping his father off to unannounced healthcare mergers, a
victory for prosecutors after an appellate ruling made it harder
to pursue such cases harder.
Read more
banker was convicted on Wednesday of engaging in insider trading
by tipping his father off to unannounced healthcare mergers, a
victory for prosecutors after an appellate ruling made it harder
to pursue such cases harder.
Read more
Monsanto gives Bayer limited access to information -sources
FRANKFURT, Aug 17 (Reuters) - U.S. seed giant Monsanto
has given German suitor Bayer limited access
to its books after turning down a sweetened $64-billion takeover
offer last month, two sources familiar with the situation told
Reuters.
Read more
has given German suitor Bayer limited access
to its books after turning down a sweetened $64-billion takeover
offer last month, two sources familiar with the situation told
Reuters.
Read more
UPDATE 2-Turkey's investigation into drugmaker Novartis 'ongoing' -official
* Novartis says still sees matter as closed, making checks
(Adds Novartis spokesman comment)
Read more
(Adds Novartis spokesman comment)
Read more
Aetna CEO warned it would cut Obamacare if Humana deal was blocked
NEW YORK, Aug 17 (Reuters) - Aetna Inc's CEO said in
a letter to the U.S. Department of Justice during the review of
its deal to buy rival Humana Inc that the insurer would
exit much of the individual Obamacare insurance market if the
agency challenged the merger.
Read more
a letter to the U.S. Department of Justice during the review of
its deal to buy rival Humana Inc that the insurer would
exit much of the individual Obamacare insurance market if the
agency challenged the merger.
Read more
BRIEF-Cytokinetics expects results from VITALITY-ALS in 2H 2017
* Cytokinetics completes enrollment in VITALITY-ALS, phase 3
clinical trial of Tirasemtiv in patients with ALS
Read more
clinical trial of Tirasemtiv in patients with ALS
Read more
BRIEF-Perrigo to acquire Geiss, Destin & Dunn
* Perrigo to acquire U.S. Distributor of Healthcare &
Consumer Goods Products, Geiss, Destin & Dunn
Source text for Eikon:
Further company coverage:
Read more
Consumer Goods Products, Geiss, Destin & Dunn
Source text for Eikon:
Further company coverage:
Read more
Hitachi, Carlyle, Permira among bidders for $1 bln Takeda unit-sources
TOKYO, Aug 17 (Reuters) - Hitachi Ltd and buyout
firms Carlyle Group and Permira are among
suitors to buy Takeda Pharmaceutical Co's chemicals
unit, people with knowledge of the matter said, in a deal that
could total around $1 billion.
Read more
firms Carlyle Group and Permira are among
suitors to buy Takeda Pharmaceutical Co's chemicals
unit, people with knowledge of the matter said, in a deal that
could total around $1 billion.
Read more
Tuesday, August 16, 2016
FEATURE-Stigma "killing" South Africans living with HIV
DURBAN, South Africa, Aug 17 (Thomson Reuters Foundation) -
T ania has to shout to be heard over music blasting out of a
brothel in downtown Durban, South Africa, where dozens of sex
workers slouch in chairs under the red glow of the bar or lean
against walls as they wait for clients.
Read more
T ania has to shout to be heard over music blasting out of a
brothel in downtown Durban, South Africa, where dozens of sex
workers slouch in chairs under the red glow of the bar or lean
against walls as they wait for clients.
Read more
UPDATE 4-FBI delivers documents on Clinton email probe to U.S. Congress
WASHINGTON, Aug 16 (Reuters) - The Federal Bureau of
Investigation said on Tuesday it had turned over to the U.S.
Congress a number of documents related to its probe into Hillary
Clinton's use of a private email server while she was secretary
of state.
Read more
Investigation said on Tuesday it had turned over to the U.S.
Congress a number of documents related to its probe into Hillary
Clinton's use of a private email server while she was secretary
of state.
Read more
PRESS DIGEST- British Business - Aug 17
Aug 17 (Reuters) - The following are the top stories on the
business pages of British newspapers. Reuters has not verified
these stories and does not vouch for their accuracy.
Read more
business pages of British newspapers. Reuters has not verified
these stories and does not vouch for their accuracy.
Read more
UPDATE 1-Haiti finds case of microcephaly linked to Zika virus
PORT-AU-PRINCE, Aug 16 (Reuters) - Haiti has identified its
first case of the birth defect microcephaly linked to the Zika
virus, a senior health ministry official said on Tuesday.
Read more
first case of the birth defect microcephaly linked to the Zika
virus, a senior health ministry official said on Tuesday.
Read more
Haiti finds case of microcephaly linked to Zika virus
PORT-AU-PRINCE, Aug 16 (Reuters) - Haiti has identified its
first case of the birth defect microcephaly linked to the Zika
virus, a senior health ministry official said on Tuesday.
Read more
first case of the birth defect microcephaly linked to the Zika
virus, a senior health ministry official said on Tuesday.
Read more
UPDATE 5-Eleven dead, thousands of homes ravaged in Louisiana floods
BATON ROUGE, La., Aug 16 (Reuters) - Search-and-rescue
operations were still underway on Tuesday in Louisiana, where at
least 11 people have died in severe floods that damaged about
40,000 homes, state officials said.
Read more
operations were still underway on Tuesday in Louisiana, where at
least 11 people have died in severe floods that damaged about
40,000 homes, state officials said.
Read more
BRIEF-Vigil Health qtrly revenue $1.66 million
* Vigil Health Solutions Inc qtrly EBITDA of $274 thousand
compared to $49 thousand in three months ended June 30, 2015
Read more
compared to $49 thousand in three months ended June 30, 2015
Read more
BRIEF-Indivior Plc announces positive top-line phase 3 study results for RBP-6000
* Announces positive top-line phase 3 pivotal study results
for rbp-6000 buprenorphine monthly depot for treatment of opioid
use disorder
Read more
for rbp-6000 buprenorphine monthly depot for treatment of opioid
use disorder
Read more
UPDATE 2-U.S. SEC cracks down on severance agreements that deter whistleblowing
WASHINGTON, Aug 16 (Reuters) - For the second time in less
than a week, U.S. securities regulators on Tuesday filed civil
charges against a company for inserting language into its
severance agreements that prevents outgoing employees from
reaping the benefits of government whistleblower awards.
Read more
than a week, U.S. securities regulators on Tuesday filed civil
charges against a company for inserting language into its
severance agreements that prevents outgoing employees from
reaping the benefits of government whistleblower awards.
Read more
BRIEF-Hitachi Group has elbowed into a race to acquire Takeda Pharmaceutical's unit with Fujifilm Holdings - Nikkei
* The Hitachi Group has elbowed into a race to acquire a
Takeda Pharmaceutical Subsidiary, raising the prospect of a
bidding war with Fujifilm Holdings - Nikkei
Read more
Takeda Pharmaceutical Subsidiary, raising the prospect of a
bidding war with Fujifilm Holdings - Nikkei
Read more
U.S. prosecutors dealt setback in medical marijuana cases
SAN FRANCISCO, Aug 16 (Reuters) - The U.S. Department of
Justice cannot spend money to prosecute federal marijuana cases
if the defendants comply with state guidelines that permit the
drug's sale for medical purposes, a federal appeals court ruled
on Tuesday.
Read more
Justice cannot spend money to prosecute federal marijuana cases
if the defendants comply with state guidelines that permit the
drug's sale for medical purposes, a federal appeals court ruled
on Tuesday.
Read more
UPDATE 1-Recordati names new CEO after death of Giovanni Recordati
MILAN, Aug 16 (Reuters) - Italian drugmaker Recordati
appointed Andrea Recordati as its new chief executive
on Tuesday following the death of his 66-year-old step-brother
Giovanni after a long illness.
Read more
appointed Andrea Recordati as its new chief executive
on Tuesday following the death of his 66-year-old step-brother
Giovanni after a long illness.
Read more
BRIEF-Radius Health says JAMA publishes positive Phase 3 data for abaloparatide
* JAMA publishes positive phase 3 data for abaloparatide in
postmenopausal women with osteoporosis
Read more
postmenopausal women with osteoporosis
Read more
UPDATE 2-Perfume maker Coty posts loss as integration costs pinch
* Coty on track to close P&G beauty brands deal in October
(Recasts to reflect share move, adds Q4 details)
Read more
(Recasts to reflect share move, adds Q4 details)
Read more
US stock buybacks at lowest level in years: report
NEW YORK, Aug 16 (IFR) - US companies have reduced stock
buybacks to the lowest level in four years, according to a new
report on Tuesday.
Read more
buybacks to the lowest level in four years, according to a new
report on Tuesday.
Read more
Congo, Angola begin mass vaccination drive against yellow fever
KINSHASA, Aug 16 (Reuters) - Democratic Republic of Congo
and Angola began one of the biggest ever emergency vaccination
campaigns in Africa this week, working with the World Health
Organization (WHO) to curb a yellow fever epidemic that has
killed hundreds this year.
Read more
and Angola began one of the biggest ever emergency vaccination
campaigns in Africa this week, working with the World Health
Organization (WHO) to curb a yellow fever epidemic that has
killed hundreds this year.
Read more
BRIEF-Chiasma adopts a retention plan to provide cash retention payments to all remaining employees
* Adopted a retention plan, effective immediately to provide
cash retention payments to all remaining employees of co- sec
filing
Read more
cash retention payments to all remaining employees of co- sec
filing
Read more
BRIEF-Pacgen announces progress on PAC-113 license
* Says its licensing partner, General Biologicals
Corporation has made significant progress on PAC-113
Read more
Corporation has made significant progress on PAC-113
Read more
BRIEF-Immunocellular Therapeutics files for non-timely 10-Q
* Expects to report a net loss of $5.3 million for three
months ended June 30, versus $3.2 million for three months ended
june 30, 2015
Source text for Eikon:
Further company coverage:
Read more
months ended June 30, versus $3.2 million for three months ended
june 30, 2015
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Guangdong Biolight Meditech revises share private placement plan
* Says it revises share private placement plan, to raise up
to 267.6 million yuan ($40.42 million)
Read more
to 267.6 million yuan ($40.42 million)
Read more
BRIEF-United BioPharma says private placement new share issue price is T$39.39 per share
* Says it will issue up to 22.5 million new shares at
T$39.39 per share through private placement
Read more
T$39.39 per share through private placement
Read more
BRIEF-Coloplast Q3 EBIT DKK 1.20 billion, below estimates
* Q3 revenue 3.69 billion Danish crowns ($559.15 million) versus 3.72 billion crowns seen in
Reuters poll
Read more
Reuters poll
Read more
BRIEF-Jantar Development Q2 net loss narrows to 9,841 zlotys yoy
* Q2 net loss of 9,841 zlotys ($2,591) versus loss of 12,634
zlotys year ago
Source text http://bit.ly/2aWvUrh
Further company coverage:
($1 = 3.7979 zlotys)
(Gdynia Newsroom)
Read more
zlotys year ago
Source text http://bit.ly/2aWvUrh
Further company coverage:
($1 = 3.7979 zlotys)
(Gdynia Newsroom)
Read more
BRIEF-ScandiDos sells Delta4Phantom+ to hospital in South Korea
Aug 16 (Reuters) - ScandiDos AB :
* Scandidos sells Delta4Phantom+ to hospital in South Korea
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
Monday, August 15, 2016
BRIEF-Actelion wins Swiss approval of uptravi for form of high blood pressure
* Says receives Swissmedic approval for uptravi (selexipag)
for treatment of pulmonary arterial hypertension
Read more
for treatment of pulmonary arterial hypertension
Read more
German stocks - Factors to watch on August 16
FRANKFURT, Aug 16 (Reuters) - The following are some of the
factors that may move German stocks on Tuesday:
Read more
factors that may move German stocks on Tuesday:
Read more
UPDATE 1-Aetna pulls back on Obamacare health insurance plans in 2017
NEW YORK, Aug 15 (Reuters) - Aetna Inc, the No. 3
U.S. health insurer, on Monday said that due to persistent
financial losses on Obamacare plans, it will sell individual
insurance on the government-run online marketplaces in only four
states next year, down from the current 15 states.
Read more
U.S. health insurer, on Monday said that due to persistent
financial losses on Obamacare plans, it will sell individual
insurance on the government-run online marketplaces in only four
states next year, down from the current 15 states.
Read more
Colorado to vote on assisted suicide in November
DENVER, Aug 15 (Reuters) - Colorado voters will decide in
November whether to legalize physician-assisted suicide for
terminally ill patients under a ballot question approved on
Monday, a proposal opposed by some religious and
disability-rights organizations.
Read more
November whether to legalize physician-assisted suicide for
terminally ill patients under a ballot question approved on
Monday, a proposal opposed by some religious and
disability-rights organizations.
Read more
Aetna cuts Obamacare exchange plans to only 4 states for 2017
NEW YORK, Aug 15 (Reuters) - Aetna Inc on Monday
said that due to financial losses on Obamacare plans, it only
will sell individual insurance on exchanges in four states next
year.
Read more
said that due to financial losses on Obamacare plans, it only
will sell individual insurance on exchanges in four states next
year.
Read more
BRIEF-ATGen signs exclusive agency agreement with PT. MEDISON JAYA RAYA
* Says it signs exclusive agency agreement with PT. MEDISON
JAYA RAYA, for its product, NK Vue KIT
Read more
JAYA RAYA, for its product, NK Vue KIT
Read more
BRIEF-Aratana Therapeutics granted FDA approval of Nocita
* Aratana Therapeutics granted FDA approval of Nocita
(bupivacaine liposome injectable suspension)
Read more
(bupivacaine liposome injectable suspension)
Read more
CORRECTED (OFFICIAL)-UPDATE 2-Drugmaker Stada's long-serving CEO Retzlaff resigns
FRANKFURT, Aug 15 (Reuters) - German drugmaker Stada
, which is facing pressure from activist investors to
overhaul its leadership, said long-serving Chief Executive
Hartmut Retzlaff, who took sick leave in June, had resigned on
Monday.
Read more
, which is facing pressure from activist investors to
overhaul its leadership, said long-serving Chief Executive
Hartmut Retzlaff, who took sick leave in June, had resigned on
Monday.
Read more
BRIEF-Jana Partners dissolves sole share stake in Pfizer, NXP Semiconductors
* Jana Partners takes sole share stake of 4.1 million shares
in Hewlett Packard Enterprise Co - SEC filing
Read more
in Hewlett Packard Enterprise Co - SEC filing
Read more
Deals of the day-Mergers and acquisitions
Aug 15 (Reuters) - The following bids, mergers, acquisitions
and disposals were reported by 1330 GMT on Monday:
Read more
and disposals were reported by 1330 GMT on Monday:
Read more
BRIEF-Apricus Biosciences says gets $4.5 mln in upfront payments from Ferring
* Company's partner in United Kingdom, has received United
Kingdom marketing authorization for Vitaros
Read more
Kingdom marketing authorization for Vitaros
Read more
Swiss stocks - Factors to watch on Aug. 15
ZURICH, Aug 15 (Reuters) - The Swiss blue-chip SMI
was seen opening 0.1 percent higher at 8303.50 points on Monday,
according to premarket indications by bank Julius Baer
.
Read more
was seen opening 0.1 percent higher at 8303.50 points on Monday,
according to premarket indications by bank Julius Baer
.
Read more
BRIEF-UCB says Delaware court confirms validity Vimpat patent
* Announced on Sunday that the Delaware District Court
confirmed the validity of U.S. patent RE38,551 related to Vimpat
Read more
confirmed the validity of U.S. patent RE38,551 related to Vimpat
Read more
Sunday, August 14, 2016
German stocks - Factors to watch on August 15
BERLIN/FRANKFURT, Aug 15 (Reuters) - The following are some
of the factors that may move German stocks on Monday:
Read more
of the factors that may move German stocks on Monday:
Read more
BRIEF-Basilea Pharmaceutica H1 net loss narrows to CHF 27.9 million
* Contract revenue in first half-year of 2016 amounted to
27.8 million Swiss francs ($28.50 million) (H1 2015: 24.4
million francs)
Read more
27.8 million Swiss francs ($28.50 million) (H1 2015: 24.4
million francs)
Read more
Shareholders' advisory firm ISS urges ousting of Stada's chairman
BERLIN, Aug 14 (Reuters) - Institutional Shareholder
Services (ISS) is advising shareholders at German generic
drugmaker Stada to vote to remove chairman Martin
Abend at the company's annual meeting this month, according to
an ISS document seen by Reuters on Sunday.
Read more
Services (ISS) is advising shareholders at German generic
drugmaker Stada to vote to remove chairman Martin
Abend at the company's annual meeting this month, according to
an ISS document seen by Reuters on Sunday.
Read more
BRIEF-Qiagen to return $250 mln to shareholders
* Qiagen announces plans to return approximately $250
million to shareholders via synthetic share repurchase proposal
Source text for Eikon:
Further company coverage:
Read more
million to shareholders via synthetic share repurchase proposal
Source text for Eikon:
Further company coverage:
Read more
UPDATE 2-U.S. declares a Zika public health emergency in Puerto Rico
CHICAGO, Aug 12 (Reuters) - The Obama administration on
Friday declared a public health emergency in the U.S. territory
of Puerto Rico, saying the rapid and widespread transmission of
the Zika virus threatens the health of infected pregnant women
and their babies.
Read more
Friday declared a public health emergency in the U.S. territory
of Puerto Rico, saying the rapid and widespread transmission of
the Zika virus threatens the health of infected pregnant women
and their babies.
Read more
Friday, August 12, 2016
BRIEF-Biocept files for common stock offering of up to $10 mln
* Files for common stock offering of up to $10 million - SEC
Filing
Source text: [http://bit.ly/2aSxvzR]
Further company coverage:
Read more
Filing
Source text: [http://bit.ly/2aSxvzR]
Further company coverage:
Read more
BRIEF-Perkinelmer Inc entered into an unsecured revolving credit facility
* Perkinelmer inc says on august 11, 2016, entered into an
unsecured revolving credit facility
Read more
unsecured revolving credit facility
Read more
BRIEF-Galena Biopharma says amended Nov 2014 purchase agreement with Lincoln Park Capital
* Amended Nov 2014 purchase agreement with Lincoln Park
Capital to increase number of shares of common stock that co can
direct LPC to buy
Source text for Eikon:
Further company coverage:
Read more
Capital to increase number of shares of common stock that co can
direct LPC to buy
Source text for Eikon:
Further company coverage:
Read more
Judge rejects Ohio law to cut Planned Parenthood funds over abortion
Aug 12 (Reuters) - A judge on Friday prevented Ohio from
cutting federal taxpayer funding from 28 Planned Parenthood
clinics, setting back the governor's hopes of stopping the
women's health services group from providing abortions.
Read more
cutting federal taxpayer funding from 28 Planned Parenthood
clinics, setting back the governor's hopes of stopping the
women's health services group from providing abortions.
Read more
REFILE-Global polio eradication hopes hang in the balance after Nigeria setback
LONDON/GENEVA, Aug 12 (Reuters) - After two years in which
the disease appeared beaten in Africa, polio eradication hopes
hang in the balance with two cases of paralysis in Nigeria
suggesting the virus has fought back, UN experts said on Friday.
Read more
the disease appeared beaten in Africa, polio eradication hopes
hang in the balance with two cases of paralysis in Nigeria
suggesting the virus has fought back, UN experts said on Friday.
Read more
U.S. judge in Anthem merger trial plans ruling by late January
WASHINGTON, Aug 12 (Reuters) - The judge overseeing the U.S.
Justice Department's bid to stop big health insurer Anthem
from merging with competitor Cigna said on
Friday her goal was to have a ruling by the end of January,
later than the Dec. 30 sought by Anthem.
Read more
Justice Department's bid to stop big health insurer Anthem
from merging with competitor Cigna said on
Friday her goal was to have a ruling by the end of January,
later than the Dec. 30 sought by Anthem.
Read more
BRIEF-China's B-Soft to acquire financial services firm for 1.2 bln yuan
* Says it plans to acquire financial services firm for 1.24
billion yuan ($186.97 million) via share issue, cash
Read more
billion yuan ($186.97 million) via share issue, cash
Read more
BRIEF-Atossa Genetics Q2 loss per share $ 0.05
* Atossa Genetics announces second quarter 2016 financial
results and provides company update
Source text for Eikon:
Further company coverage:
Read more
results and provides company update
Source text for Eikon:
Further company coverage:
Read more
BRIEF-MediBIC Group gets approval to extend submitting of Q2 report for FY 2016
* Says it has received the approval to extend the deadline
of submitting the second quarter report for fiscal year ending
Dec. 2016 to Sep. 15, instead of Aug. 15
Read more
of submitting the second quarter report for fiscal year ending
Dec. 2016 to Sep. 15, instead of Aug. 15
Read more
BRIEF-Zealand Pharma: supportive results from Phase II trial of dasiglucagon
* Announced on Thursday supportive results from a Phase II trial with a single-dose version
of dasiglucagon as rescue treatment of severe hypoglycemia
Read more
of dasiglucagon as rescue treatment of severe hypoglycemia
Read more
BRIEF-Anges MG to work together with Vical Incorporated on DNA vaccine business
* Says the company and Vical Incorporated has agreed to work
together on DNA vaccine business, which includes research,
development and manufacturing
Read more
together on DNA vaccine business, which includes research,
development and manufacturing
Read more
Thursday, August 11, 2016
BRIEF-Infoscan Q2 net loss widens to 398,157 zlotys
* Reported on Thursday Q2 revenue of 20,699 zlotys ($5,415.18) versus
13,499 zlotys a year ago
Read more
13,499 zlotys a year ago
Read more
Gilead to get attorney fees in hepatitis C patent fight with Merck
Aug 11 (Reuters) - Gilead Sciences Inc is entitled
to receive the attorney fees it incurred related to hepatitis C
patent litigation with drugmaker Merck & Co Inc, a U.S.
district judge has ruled.
Read more
to receive the attorney fees it incurred related to hepatitis C
patent litigation with drugmaker Merck & Co Inc, a U.S.
district judge has ruled.
Read more
BRIEF-Northwest healthcare properties REIT Q2 adjusted FFO per share C$0.22
* Qtrly revenues from investment properties of $64.2
million, increase of 43% over same period last year
Read more
million, increase of 43% over same period last year
Read more
BRIEF-Cempra appoints David Zaccardelli to board of directors
* Cempra appoints Dr. David Zaccardelli to board of
directors
Source text for Eikon:
Further company coverage:
Read more
directors
Source text for Eikon:
Further company coverage:
Read more
AstraZeneca wins UK cost approval for longer use of heart drug
LONDON, Aug 12 (Reuters) - Long term use of AstraZeneca's
blood thinner Brilinta has been recommended as a
cost-effective option for treating patients after a heart
attack, Britain's healthcare cost watchdog NICE said on Friday.
Read more
blood thinner Brilinta has been recommended as a
cost-effective option for treating patients after a heart
attack, Britain's healthcare cost watchdog NICE said on Friday.
Read more
Subscribe to:
Posts (Atom)